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ABSTRACT
Synthetic polynucleotides have been shown to exhibit antiviral 
properties in a variety of biological systems. This thesis describes 
the synthesis and properties of some novel and potentially active 
compounds.
Poly hydroxyadenylate and polyisoxanthylate, both potential
interferon inducers, were prepared by the enzymatic polymerisation of
their corresponding nucleoside 5'“diphosphates. N -hydroxyadenosine
5'“ diphosphate was obtained from 6-thioinosine 5'“diphosphate by a
£
simple substitution reaction. Poly N -hydroxyadenylate shows the 
properties of a highly stacked, single-stranded polynucleotide and forms 
a hydrogen-bonded complex with polyxanthylate. Polyisoxanthylate, 
which displays some unusual physical characteristics, forms a double­
stranded complex with polyadenylate.
The inhibitory potential of a polynucleotide might be increased 
by introduction of a sulphur substituent. 6-Thioinosine 5''diphosphate 
alone will not act as a substrate for polynucleotide phosphorylase 
but can be incorporated into a copolymer withinosine 5'-diphosphate. 
Compared with polyinosinate, the thiolated copolymer exhibits a loss 
of secondary structure and also a loss of in vivo antiviral activity 
in mice. However, as the 6-thioinosine content increases, the 
polynucleotides show a greater degree of inhibition against a viral 
reverse transcriptase in vitro.
Poly 4”thiouridylate was conveniently prepared by thiolation of 
polycytidylate with liquid hydrogen sulphide. A combination of enzymatic 
and chemical phosphorylation procedures furnished the 5'“diphosphates of 
2,4~dithiouridine and 2-thiocytidine. These were incorporated into 
polynucleotides by the action of polynucleotide phosphorylase. The 
thiolated polynucleotides exhibit excellent inhibitory potency in an 
in vitro reverse transcriptase assay.
The initial deoxynucleotide sequence of the reverse transcript from 
the genome of three distinct tumour viruses is d(AATGAA). The synthesis 
of this conserved, 'strategic' sequence and closely related structures 
was carried out. The presence of this hexadeoxynucleotide in a 
reconstituted tumour virus assay system stimulated the transcription 
reaction. The significance of this finding and the potential for the 
design of antiviral agents is discussed.
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EMCV Bncephalomyocarditis Virus
AMY Avian Myeloblastosis Virus
RSV Rous Sarcoma Virus
MMLV Moloney Murine Leukaemia Virus
PNPase Polynucleotide Phosphorylase
CPTase Carrot phosphotransferase
SVPDase Snake venom phosphodiesterase
BAP Bacterial alkaline phosphatase
Tris Tris (hydroxymethyl) aminomethane
HEPES N-2-hydroxyethylpiperazine - N'-2-ethane sulphonic acid
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GENERAL INTRODUCTION
The word virus is a term which was used for hundreds of years 
to denote all types of poisonous and infectious agents. During the
last century it was recognised that these harmful agents could be 
differentiated into two classes. The classification distinguished 
between chemical toxins and pathogenic micro-organisms. Later, 
bacteriologists observed that some pathogens were capable of passing 
through filters which normally retained all micro-organisms, and in 
this respect resembled the simple poisons. Nevertheless, it was 
shown that these pathogens could be serially transmitted through 
many passages to many hosts. These agents were called filterable 
viruses and now simply viruses.
Research into the biochemical properties of viruses has coincided 
with research into bacterial pathogens, and the development of antibiotics. 
Prom the empirical observation that fungi secrete chemical compounds 
capable of inhibiting bacteria, the development of new, more efficient 
synthetic analogues has helped to combat many microbial diseases of 
humans. The success of antibiotic research has left viruses as the 
most threatening human pathogens.
Most cells, including those of animals, plants and bacteria are 
susceptible to viral infection and the discovery of a general, or in 
some cases a specific antiviral agent would be of enormous value.
There exists two main approaches for the elimination of viral 
infections in animals. The first involves the use of vaccines which, 
when injected into healthy animals,induce the formation of antibodies 
(Neficy and Nategh, 1972) that are capable of neutralising pathogenic 
viruses. This approach has been developed since the beginning of the 
century and has involved the use of inactive or attenuated live virus.
Such immunisation is limited by the fact that the vaccines are generally 
specific against only one viral strain and in some cases these are 
continually evolving (eg influenza virus). The second approach has 
involved the search for chemical compounds which are capable of 
specifically inhibiting one or more viruses at a particular stage 
during their replicative cycle. In 1950, Hamre et al made a start 
by systematically searching for antiviral substances. Random screening 
of compounds has continued since then, (Hfllemann, 1965; Tamm and 
Eggers, 1965), but as more knowledge about viruses accumulates it 
has become increasingly possible to design antiviral compounds from 
a theoretical aspect.
Success in the search for clinically useful antiviral agents has 
been very poor and there has been considerable debate as to where future 
research should be aimed (Rubin and Haff, 1970; Hillemann, 1969). The 
design and use of antiviral agents is limited for two main reasons. 
Viruses are cellular parasites, and as such utilise host cell components 
for most of their replicative cycle. Hence the first problem is one 
of selective toxity. It is necessary to find a compound capable of 
blocking a process specified by the viral genome although in most cases 
these processes will be very similar to those taking place in uninfected 
cells. The second problem is that viruses often complete several rounds 
of replication, with ensuing cell damage, before the symptoms are 
recognised (eg rabies virus).
For the successful design of antiviral chemotherapeutic agents 
it is necessary to have an understanding of the processes involved in 
viral replication. The genetic information of viruses is specified 
by nucleic acid. This is generally enclosed within a protein coat, 
which is not only used as protection but also confers host specificity 
to the virus particle. Viruses have been classified according to their 
type of genetic material, for example whether it is ribo- or deoxyribo­
nucleic acid and whether it is single or double stranded. The 
classification system due to Melnick (1974) includes also the nature 
of the coded viral proteins as well as the cellular site of replication.
The basic events which take place during viral replication can be 
considered in several stages.
1) Adsorption. Viral coat proteins recognise and bind to specific 
receptor sites on a limited range of host cells.
2) Penetration. This is achieved by a variety of mechanisms depending 
on the virus, but animal viruses are probably taken into cells by 
natural pynocytosis.
3) Uncoating. Cellular processes are stimulated to degrade the coat 
proteins and release the viral nucleic acid.
The metabolic processes of cells are usually altered after 
virus infection. This is brought about by changes in the rates of 
cellular DNA, RNA. and protein synthesis (McCorquodale et al, 1976; 
Keir, 1968).
4) Transcription. This is achieved by activation of a virion 
associated polymerase or by a cellular transcriptase.
5) Translation. Viral mRNA associates with cellular ribosomes to 
synthesise viral proteins.
6) Replication. For viruses containing single-stranded ENA (eg EMCV) 
this stage relies on previous translation to synthesise the viral 
coded ENA-dependent ENA polymerase. Interaction of this enzyme 
with the viral RNA template normally takes place in association with 
membranous structures to produce the replicative intermediate and 
the replicative form of the RNA.
7) Assembly. The maturation of progeny virus particles, from viral 
nucleic acid and coat proteins, is either spontaneous (Leberman, 1968) 
or involves a series of virus controlled stages (Wood and Edgar, 1967) 
directed by proteins such as the maturation protein (Hohn, 1967).
8) Release. Viral interference with the cellular metabolic processes 
can lead to the eventual death and lysis of the cells releasing the 
progeny virus particles to the surrounding medium. In some cases 
the virus actively causes the lysis of the host cell by coding for
a protein (lysozyme) to digest the cell wall (Streisinger et al, 1961). 
All these stages during viral replication present potential sites 
for antiviral action. A large number of compounds with antiviral 
activity have been discovered. The mechanisms of action of most of 
these compounds have been elucidated and shown to act at one or more of 
the stages during viral replication. (For reviews see Prusoff and Goz, 
1975; Shugar, 1974; Diana and Pancic, 1976; Becker, 1976). However, 
because of the intimate relationship between virus and host cell the 
majority of these compounds are too toxic to be of clinical value.
Only four compounds are known to be effective in humans (Weinstein and 
Chang, 1973) and even these can lead to complications.
Methylisatin“3”thiosemicarbazone (methisazone) (l) (Fig. l) is 
used in the prophylaxis of smallpox virus (Bauer, 1972, 1973) and is 
thought to act by degradation of late mRNA molecules, after attachment 
to ribosomes (Woodson and Joklik, 1965).
Amantadine hydrochloride (2) (Fig. l) is used in the prophylaxis 
of influenza virus (Wingfield et al, 1969) and blocks or slows down the 
penetration of the host cell by the virus (Davies et al, 1964)*
Idoxuridine (3) and Cytarabine (4) (Fig. l) are used therapeutically 
against herpes virus (Kaufman, 1965* 1972; Jawetz, 1973)* They are 
incorporated into DNA and inhibit enzymes involved in DNA synthesis.
FIGURE 1
Chemical structure of some antiviral agents
(1) Methylisatin-3“thiosemicarbazone
(2) Amantadine hydrochloride
(3) Idoxuridine
(4) Cytarabine
figure 1
(1)
i\j-nh-cs-nh2 
0
(2)
The purpose of the work described in this thesis was to design and 
synthesise polynucleotides with potential antiviral activity. With 
prior knowledge of the general processes involved in viral replication, 
the remaining part of the introduction outlines in more detail the 
background to the particular polynucleotides described in the 
following chapters.
INTERFERON
When a virus invades an animal host the natural defence mechanisms 
of the latter are switched on. A possible chemotherapeutic approach 
is to stimulate this process. One such mechanism involves interferon,
a glycoprotein (Schonne et al, 1970) stable over a wide pH range.
Since its discovery by Isaacs et al (1957) interferon has been the 
subject of much research and many reviews have been published (Vilcek, 
1969; DeClercq and Merigan, 1970; Rodgers and Merigan, 1972; Grossberg, 
1972; Joklik, 1977)* Many animal viruses (Isaacs, 1964; Wolstenholme 
and 0!Connor, 1968; Harris, 1970; Colby, 1971) and double-stranded 
RNAfs (Lampson et al, 1967; Field et al, 1967) stimulate the production 
of interferon in animal cells. Interferons are mainly species specific 
although some are active in heterologous species (Finter, 1975)- The 
most thoroughly investigated interferon inducer is the synthetic double­
stranded RNA, poly (i). poly (c), but it is not clear whether induction 
requires cellular uptake or whether it is triggered from the cell membrane 
(Wagner et al. 1971; Schell, 1968). Interferon production is inhibited 
by actinomycin D and cycloheximide (Vilcek, 1969) suggesting that 
transcription of interferon mRNA and its subsequent translation are 
essential processes (Wagner, 1963* Field et al, 1968; DeMaeyer-Guignard 
et al, 1972). Interferon is released from the induced cell into the 
surrounding medium where it interacts with the membrane of recipient 
cells, (Friedman, 1967; Berman and Vilcek, 1974)* But with very little 
uptake (Buckler et al. 1966). This induces de novo transcription 
and translation of the * second antiviral protein’ (Taylor, 1964;
Kerr et al, 1970; Friedman and Sonnabend, 1964). Marcus and Salb (1966) 
showed that this protein inhibited viral translation whilst cellular 
translation is unaffected. This is probably achieved by altering the 
affinity of cellular ribosomes for cellular and viral mRNA.
The clinical value.~of poly (i). poly (c) is severely limited by its 
toxic side-effects (Absher and Stinebring, 1969; Philips et alt 1971) 
and many modified polynucleotides have been synthesised in an effort to 
improve the therapeutic ratio (toxicity divided by antiviral activity)
(Black et al, 1973; DeClercq, 1974)* Prom such studies some requirements 
for polynucleotide interferon inducers have been deduced. One requirement 
appears to be the necessity for a double-stranded complex (DeClercq, 1974)• 
There may be exceptions to this rule, although under the conditions used, 
the possibility of double- or multi-stranded complexes cannot be ruled 
out (DeClercq and Merigan, 1969; Thang et al, 1977)* The most stringent 
requirement appears to be the presence of the 2'-hydroxyl group in both 
strands of the polynucleotide complex (Hutchinson et al, 1974)* In all 
cases where the 2 '-hydroxyl group has been replaced by other substituents 
there has been a significant decrease in the antiviral activity (DeClercq, 
1974). The effect of other modifications cannot be generalised in such 
a manner. An optimum size of between 5S and 10S (10^  to 12 x 10^  daltons) 
for each strand is important for antiviral activity (Lampson et al, 1970)• 
Although interferon induction has been shown to be a rapid event (Pitha 
et al, 1972) there is some evidence to suggest that a good polynucleotide 
interferon inducer should be reasonably resistant to degradation by 
nucleases (DeClercq et al, 1969; Pitha and Carter, 1971)* In any case 
the sera of various animals contain nucleases capable of degrading 
double-stranded RNA (Nordlund et al, 1970; Stern, 1970). Conversely, 
the resistance to nucleolytic degradation may increase the toxic side 
effects of such complexes by increasing their lifetime in the animal.
It has been observed that all double-stranded polynucleotides with a com­
paratively good antiviral activity exhibit a thermal ’melting temperature*
(Tm) above 60°. All complexes with a Tm below 40° and which are thus 
dissociated at incubation temperature do not show any appreciable anti­
viral activity (DeClercq et_ al, 1970). There are examples of double­
stranded polynucleotides which satisfy all the above requirements and 
yet have a very low inducing activity (eg poly (A), poly (N)). It could 
be that interferon induction is solely dependent on the recognition of 
a particular steric arrangement .of a polyanion (Bobst et al, 1967). The 
majority of modificiations to poly (l). poly (c) have involved the poly (c) 
strand, without significant effect on the therapeutic ratio- However
there is some evidence to suggest that the poly (i) strand is the more 
important for the induction of interferon (DeClercq et_al, 1973)* 
Modification of the bases in this strand could potentially have a 
greater effect. Chapters 1, 2 and 3 of this thesis describe the 
synthesis and properties of three poly (i) analogues.
POLYCYT IDYLATE ANALOGUES
A polynucleotide which is identical with or complementary to a 
specific, strategic sequence within a viral genome has the potential 
to compete with or bind to this sequence and possibly inhibit either 
transcription, translation or replication.
Encephalomyocarditis virus (EMCV) contains a continuous single­
stranded RNA genome of about 7600 nucleotides (Granboulan and Girard, 1969). 
It contains a single translation initiation site (Oberg and Shatkin, 1972) 
giving rise to a single polypeptide (Butterworth and Hall, 1971) which is 
later cleaved to structural and functional proteins. It has been shown 
that native EMCV RNA contains a single-stranded poly (C) sequence about 
100 nucleotides long (Goodchild et al, 1975; Porter et al, 1974) near 
to the 3'-terminus of the genome (Chumakov and Agrl, 1976). Since the 
amount of proline present in EMCV specific proteins is relatively small 
(Rueckert, 1971) it is likely that the poly (c) tract exists to the 
5'"side of the single translation initiation site. Although the function 
of the poly (c) tract is unclear it is probably involved with the regulation 
of either translation or replication by interaction with ribosomes or a 
viral replicase (Weber et al, 1972). The poly (c) tract provides a 
strategic sequence for the design of antiviral agents and it is interesting 
to note that both poly (C) and the complementary polynucleotide poly (i) 
show antiviral activity against EMCV infections in mice without induction 
of interferon (Stebbing at al, 1976a). The mechanism of the antiviral 
activity shown by these single-stranded polynucleotides is not known but 
there is evidence that macrophages play an intermediary role (Stebbing 
et al, 1976b). Macrophages are known to support the replication of 
EMCV (Eustatia et al, 1972) and to take up large molecules by pinocytosis. 
Therefore it is possible that the antiviral activity of poly (c) and 
poly (i) involves competition with or hybridisation to the viral poly (c) 
tract. Poly (A) and poly (tf) are not antiviral under identical conditions 
(Stebbing at al, 1976a).
Singletstranded polynucleotides have also been shown to inhibit 
bacteriophage and oncornavirus polymerases (Pitha, 1973; Tennant et al, 
1973; Chandra et al, 1975) By competing for the template Binding site on 
the polymerase enzymes.
Chapter 4 of this thesis describes the synthesis and properties 
of several thiolated poly (C) analogues and their antiviral activity 
in mice against EMCV infection. Chapter 6 deals with the inhibitory 
potential of these and other single-stranded polynucleotides in an 
in vitro oncornavirus RNA-dependent DNA polymerase assay.
STRATEGIC OLIGODEOXYMJCLBOTIDES
Since the discovery of an RNA-dependent DNA polymerase in the 
virion of oncornaviruses (Baltimore, 1970; Temin and Mitzutani, 1970) 
a lot has been learnt about their mechanism of replication. The viral 
genome consists of a 70S RNA complex which can be dissociated into 
35S RNA subunits and several low molecular weight species (Duesberg, 1968; 
Bader and Steck, 1969; Erickson, 1969). Avian myeloblastosis virus (AMV) 
and Rous sarcoma virus (RSV) each contain two identical 35S RNA molecules 
of about 10,000 nucleotides (Billeter at al, 1974; Beemon at al, 1974; 
Quade et al, 1974)* Each 35S RNA contains a tightly bound 4S RNA 
identical to the cellular tryptophan tRNA (Sawyer and Dahlberg, 1973;
Sawyer et al, 1974; Eiden et al, 1975). The tRNA^ rp is essential for 
transcription of the natural template by acting as a primer for RNA- 
dependent DNA polymerase at a site about 110 nucleotides from the 
5'"terminus of the genome (Canaani and Duesberg, 1972; Dahlberg et al, 
1974; Taylor and Illmensee, 1975). The nascent DNA is covalently 
linked to the primer tRNA which is later removed to yield after 
replication double-stranded DNA (Taylor e£ al, 1974; Sawyer and 
Dahlberg, 1973; Varmus et, al, 1974). The initial sequence of the 
transcribed DNA has been determined as d(AATGAAGC) for RSV and AMV 
and d (AATGAAAGA) for Moloney murine leukaemia virus (MMuLV) (Taylor 
et al, 1974; Eiden et al, 1975; Haseltine et al, 1976). The 
remarkable similarity of these conserved sequences suggests a common, 
important functional role for them. The first six nucleotides, 
d(AATGAA), provide a strategic sequence for the design of compounds 
capable of interfering with viral transcription.
The synthesis and biological properties of this hexadeoxynucleotide 
and related oligodeoxynucleotides are described in chapter 5«
The final part of the introduction outlines the methods available 
for the synthesis and structural determination of polynucleotides.
POLYNUCLEOTIDE SYNTHESIS
The synthesis of polyribonucleotides is normally carried out using 
the enzyme polynucleotide phosphorylase (EC.2.7.7.8)• This enzyme,
which is widely distributed in nature, was first discovered by Grunberg- 
Manago and Ochoa (1955) in extracts of Azotobacter agile. It catalyses 
the reversible polymerisation of nucleoside 5"“diphosphates according to 
the equation:-
n ppN *=* (pN)n+ nl\ (Grunberg^ Manago, 1963)
Polynucleotide phosphorylase will accept many modified nucleotides as 
substrates for polymerisation (Griffin et al, 1964; Hagenberg at al, 
1973? Simuth at al, 1970).
The synthesis of nucleoside 5"“diphosphates has, until recently, 
been a complicated procedure. A nucleoside contains several functional 
groups and the specific phosphorylation of the 5"“hydroxyl group 
necessitated the protection of other reactive sites. The classical 
approach is to protect the 2'- and 3"“hydroxyl groups with the 
isopropylidene group. The product is then specifically phosphorylated 
by condensation with p-cyanoethylphosphate in the presence of 
dicyclohexylcarbodiimide (Tener, 1961). The protecting group is then 
removed by mild acid treatment. A number of reactions based on this 
principle have been employed using different protecting groups and 
phosphorylating reagents. A variation is the use of S-ethylphosphoro- 
thioate which can be deprotected by treatment with iodine (Cook et al, 
1969). More recent methods have involed the controlled use of 
phosphorus oxychloride. In certain solvents this reagent is specific 
for the 5"“hydroxyl group and prior protection of other potentially 
reactive groups is unnecessary. (Strobach, 1969; Yoshikawa et al, 1967; 
Sowa and Ouchi, 1975). Enzymatic phosphorylation methods have been 
described (Brunngraber and Chargaff, 1967; Giziewicz and Shugar, 1975)» 
and these are particularly valuable when using rare or chemically 
reactive nucleosides. The two best examples are the phosphotransferases 
from carrots and from wheat shoots since they will accept as substrates 
a wide range of modified nucleosides.
The preparation of a ruucleoside 5'“diphosphate requires the prior 
activation of the corresponding monophosphate with a good leaving group.
The activating reagents most commonly employed are diphenylphosphoro- 
chloridate (Michelson, 1964)» l#-carbonyldiimidazole (Cramer and 
Neunhoeffer, 1962), a mixture of morpholine and dicyclohexylcarbodiimide 
(Moffatt and Khorana, 1961) and S-ethylphosphorothioate (Cook et al, 1969)* 
Enzymic methods have been used for the preparation of nucleoside 5*“ 
diphosphates but they are not generally applicable. The nucleoside 
monophosphate kinases from yeast (Lieberman et all 1955) and from calf 
liver (strominger et al, 1959) are obtainable only in small quantities 
and have a very narrow substrate range.
STRUCTURE DETERMINATION
For the design of new antiviral agents or the improvement of 
existing ones it is necessary to have an understanding of the structural 
requirements for a certain biological effect. Apart from the chemical 
identity of a particular polyribonucleotide a consideration of the spatial 
arrangement of the functional groups may play an important role in 
determining their interaction with certain receptor sites. The 
secondary structure of a single-stranded polynucleotide is mainly 
influenced by stacking interactions between neighbouring hydrophobic 
bases and repulsion between the negatively charged phosphate groups.
The classical approach to polynucleotide structural determination 
is X-ray diffraction analysis (Rich et al, 1961; Langridge and Rich, 19&5; 
Amott et al, 1974) • The overall structure of the more common 
homopolyribonucleotides has been elucidated in this manner. The method 
has only a limited value since it is time consuming, complicated and can 
only be applied to crystallisable systems. In vivo, polynucleotides 
exist in dilute aqueous solution and significant structural differences 
from the crystalline state may occur. Optical methods are the most 
widely used to study polynucleotide solution conformations. They 
include ultraviolet and infrared absorption and circular dichroism.
For reviews of these topics see Hartman ert al, 1975; Bush and Brahms,
1975; Bush, 1974.
The ultraviolet absorption of a polynucleotide (A^ ) is generally 
less than the sum of the absorptions of the individual components (A )^.
This phenomenom is termed hypochromicity and arises mainly from the 
intramolecular stacking interactions between neighbouring bases in the 
polynucleotide chain. The total hyperchromicity of a polynucleotide 
can be measured by degradation to the component monomers, either 
chemically or enzymatically. The hypo chromi city (H) is given by the 
equation:-
= -si f -  * 100^
and can be used as a measure of the degree of stacking within a 
polynucleotide. Heating a solution of a polynucleotide weakens 
the stacking interactions and this effect can be observed by following 
the variation of ultraviolet absorption with temperature. The thermal 
hyperchromicity is given by the equation:-
u _ AC0IL ~ -^ HELIX _w
^HERML “ Xl00^
The mid-point of this transition is called the melting temperature 
(Tm) and is used as a measure of the stability of the stacking 
interactions.
The circular dichroic spectrum of a polynucleotide gives a 
measure of the difference between the absorptions of left and right 
circularly polarised light. For a polynucleotide this can be used to 
extract information regarding the orientation of the ultraviolet 
absorbing chromophore (ie the base) relative to the optically active sugar.
All the information obtained from these physical, structural determination 
techniques can be combined to give an overall picture of the secondary 
structure adopted by a particular polynucleotide. In this way it may be 
possible to understand the reason for a certain biological effect caused 
by a structural modification.
CHAPTER 1
POLY N6-HYDROXYADEHYLATE
INTRODUCTION
The double-stranded complex between polyriboinosinate and 
polyribocytidylate has been shown to have antiviral properties, 
mediated by the protein interferon. The therapeutic value of 
poly (i). poly (c) is limited by side effects similar to those 
observed with bacterial endotoxin (DeClercq and Merigan, 1970).
In an effort to improve the therapeutic ratio of double-stranded 
polynucleotides many sugar, base and phosphate modified polymers 
have been prepared (Black et al, 1973; DeClercq, 1974)* Modification 
of the bases in the poly (c) strand has not significantly improved 
the therapeutic ratio. However, the poly (i) strand has been 
shown to be more important than the poly (c) strand for the 
induction of interferon (DeClercq et al, 1973) and modification of 
poly (i) may be expected to have a greater influence on the 
biological properties of the complex. The double-strandedness 
of a homopolyribonucleotide duplex is important for induction of 
interferon and so any base modification used should not destroy the 
possibility of intermolecular hydrogen-bond formation.
Poly N^ -hydroxycytidylate has been shown to interact with
polyadenylate (Smrt, 1970) and a possible Watson-Crick type base
pairing scheme is shown in figure 2. N^ -hydroxycytidine can be
produced by the exposure of cytidine residues in RNA to hydroxylamine
and the Watson-Crick hydrogen-bonding scheme would account for the
observed mutagenesis involving the transition CG —► TA (Freese et al,
£
1961). It was hoped that poly N -hydroxyadenylate would also exist 
in the imino tautomeric form and hydrogen-bond with polycytidylate as 
shown in figure 2.
6 6The replacement of the 0 ...H N hydrogen-bond in poly (i).
poly (c) by a weaker N^...H N^  bond in *poly (N^ -OHA). poly'(c)'
could be expected to reduce the melting temperature of the complex, 
but since interferon inducing ability is not dependent on T above 
about 60°, this reduction would not necessarily be detrimental.
FIGURE 2
A possible base pairing scheme for the interaction 
between poly (N^ -QHC) and -polyfA) and between 
poly(N^ -QHA) and poly(c)
The Watson-Crick type base pairing is taken from 
Phillips and Brown (19&7) an(* also Shugar et al (1976)
figure 2
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The study of poly N -hydroxyadenylate is also of interest in 
relation to hydroxylamine mutagenesis, since N^ -hydroxyadenosine 
can be produced in low amounts by the reaction of hydroxylamine with 
adenosine residues in nucleic acids.
EXPBRLMTAL
Materials
6-Thioinosine and N -hydroxyadenosine were obtained from the 
Sigma Chemical Company Ltd.
Polynucleotide phosphorylase from M. luteua, snake venom 
phosphodiesterase and spleen phosphodiesterase were obtained from 
Boehringer Mannheim GmbH.
Ribonucleases T, and were obtained from Koch-Light 
Laboratories Ltd.
Bacterial alkaline phosphatase was obtained from Hopkin and 
Williams•
Acrylamide and N,N'-methylenebisacrylamide (electrophoresis 
grade) were obtained from British Drug Houses.
Fluorescent cellulosethin layer chromatography plates were 
obtained from Macheiy-Nagel and Co.
Methods
Methyl cyanide was dried over and distilled from phosphorus 
pentoxide and stored over calcium chloride.
Pyridine was distilled from sodium hydroxide and stored over 
molecular sieve 4A-.
Dimethylformamide was dried over and distilled from phosphorus 
pentoxide and stored over molecular sieve 4A.
Ultraviolet absorption spectra were recorded using a Pye-Unicam 
SP1800 ultraviolet spectrophotometer. Temperature profiles were 
obtained using the Pye-Unicam SP876 temperature program controller. 
Samples were placed in stoppered, 1 cm path length semi-micro cuvettes
Nuclear magnetic resonance spectra were recorded in deuterated 
d^ -dimethylsulphoxide using a Perkin-Elmer EM36O 60 MHz spectrometer.
Circular dichroic spectra were recorded using a Cary 61 
spectrometer.
Phosphate Analysis
Phosphate analyses were carried out essentially by the method 
of Fiske and Subbarow (1925).
Two reagents were made up; ANSA reagent containing l-amino-2- 
napthol“4~sulphonic acid (O.lg), sodium metabisulphite (5*5g) and 
sodium sulphite heptahydrate (l.2g) dissolved in water (50 ml);
Molybdate reagent containing ammonium molybdate (5g) dissolved in 
15$ sulphuric acid (100 ml),
A known quantity of sample (about 0.5 mg) was dissolved in water 
(about 4 ml). ANSA reagent (0 .4 ml) and molybdate reagent (0.8 ml) were 
added and made up to 10 ml with water. After 10 mins. at room 
temperature the absorption at 660 nm was measured. The reading was 
converted to phosphate molarity by use of a standard calibration curve.
Organic phosphate esters were hydrolysed by pretreatment of a 
dried sample with 72$ perchloric acid (0 .4 ml) for 4 hours at 180°.
Total inorganic phosphate was then measured as described above.
Chromatography
Column chromatography was carried out on A25 DEAE-Sephade-x in the 
bicarbonate ion form. Up to 100 mg of material was chromatographed on 
a column 50 x 1.6 cm and over 100 mg on a column 60 x 2.3 cm. A linear 
gradient of 0.05M TEAB (H) to 0.5M TEAB (lC) was used.
The pooled fractions were co~evaporated with methanol under vacuum.
Thin layer chromatography was carried out on cellulose plates using 
the following solvent systems
1) iso~biityric acid/lM ammonia/O.lM EDTA 100j60:1.6
2) 1M ammonium acetate/ethanol 1:1
Electrophoresis
Polyacrylamide gel electrophoresis was carried out in formamide 
under denaturing conditions. Formamide (60 ml) was deionised by 
stirring with Amberlite monobed resin MB-1 until the specific conductance 
fell to below 5/*mho. The resin was removed by filtration. Acrylamide 
(0.85 g), N, N'-methylenebisacrylamide (0.15 g), diethylbarbituric acid 
(0.0921 g) and N,N,N',N'-tetramethylethylenediamine (0.06 ml) were 
dissolved in deionised formamide (20 ml) and adjusted to pH9.0 with 
1M hydrochloric acid. Ammonium persulphate solution (0.2 ml, 18$) 
was added and the volume made up to 25 ml with deionised formamide.
This was poured into a slab gel mould. The lyophilised sample (about 
100 g) was dissolved in 50 jti. buffered formamide (0.0921 gdiethyl 
barbituric acid dissolved in 25 ml deionised formamide and adjusted to 
pH9.0 with]M.sodium hydroxide) and 10^ *1 glycerol added. The sample
was applied to the gel and overlayed with buffered formamide. Sodium 
chloride solution (0.02M) at 60° was continuously circulated between the 
upper and lower reservoirs. The electrophoresis was typically carried 
out at 30 mA and 80 V for about 3 hours. The gel was removed from 
the mould and immersed in acidic toluidine blue solution (0.05 mg/ml 
toluidine blue, 1 M citric acid) for 16 hours. The gel was washed 
with several changes of distilled water for 24 hours.
6-Thioinosine 5'-monophosphate
6-Thioinosine (500 mg; I.76 mmole) was dried under vacuum in a 
dessicator for 24 hours and added to a solution containing 98$ formic 
acid (0.22 ml), dry methyl cyanide (1.8 ml), phosphorus oxychloride 
(l ml) and dry pyridine (l ml). The mixture was shaken vigorously for 
1 hour at room temperature and added to stirred iced water (20 ml). 
Inorganic phosphate was precipated by careful adjustment of the pH to 
10 with 2 M lithium hydroxide solution. After centrifugation the 
supernatant was neutralised with lydrochloric acid and chromatographed 
on DEAE-Sephadex. 6-Thioinosine 5'“monophosphate was obtained in a 
yield of 80$ of theoretical as determined by ultraviolet absorption.
The ultraviolet spectrum at pH 5*5 showed X = 322 nm.
nicix
in solvent system (l) = 0.21 
R^ in solvent system (2) ® 0.30
The product contained 0.97 moles of phosphorus per mole of 
nucleotide as determined by organic phosphate analysis.
6-Thioinosine 5'-diphosphate
The triethylammonium salt of 6-thioinosine monophosphate 
(1.41 mmole) was dissolved in 20$ aqueous pyridine and passed through 
a column of Dowex 50 in the pyridinium ion form. The material was 
eluted with 3 bed volumes of 20$ aqueous pyridine and evaporated to 
dryness under vacuum. The residue was dissolved in hexamethyl- 
phosphorictriamide (5 ml) and tri-n-butylamine (0.5 ml) and dried by 
co-evaporation with dry pyridine under vacuum. Pyridine was removed 
by co-evaporation with dry dimethyformamide under vacuum. 1,1' 
Carbonyldiimidazole (2g) was added and the reaction mixture kept in a 
dessicator for 4 hours. Excess reagent was destroyed by treatment with 
methanol (1.5 ml) for 30 mins. A solution of 1 M phosphoric acid (20 ml) 
and tri-n-butylamine (5 ml) in hexamethylphosphorictriamide (20 ml) was 
dried by co-evaporation with pyridine under vacuum. The residual pyridine 
was removed by evaporation with dry dimethylformamide under vacuum. This
solution was added to the activated nucleotide solution and left for 
22 hours in a dessicator at room temperature. The reaction mixture 
was added dropwise to vigorously stirred dry ether (l*E ). A white 
precipitate was allowed to settle and the ether decanted. The solid 
was dissolved in water and chromatographed on DEAE-Sephadex.
6-Thioinosine 5'“diphosphate was obtained in a yield of 60$ of 
theoretical as determined by ultraviolet absorption.
The ultraviolet spectrum at pH 5*5 showed Amax= 322 nm.
R^  in solvent system (l) = 0.10.
R^  in solvent system (2) = 0.23.
The product contained 1.99 moles of phosphorus per mole of 
nucleotide as determined by organic phosphate analysis.
Characterisation of 6-thioinosine 5'~ diphosphate
1) Preparation of the 2', 3'“isopropylidene derivative.
Acetone (2.6 ml), 2,2-dimethoxypropane (0.1 ml) and 72$ aqueous 
perchloric acid (0.1 ml) were shaken in a stoppered tube for 5 mins.
This solution (1.5 ml) was added to dry 6-thioinosine 5'“diphosphate 
(l mg) and shaken for 20 mins. Dry pyridine (l ml) was added and the 
solution evaporated under vacuum to give a solid. This showed only 
one spot by t.l.c. in two solvent systems.
R^  in solvent system (l) = 0.60.
R^  in solvent system (2) = 0,52.
2) Preparation of the 2% 3'“dialdehyde derivative.
6-Thioinosine 5'“disphosphate (l mg) was dissolved in 1 M sodium 
periodate solution (0.5 ml). The solution was left for 3 hours at room 
temperature and evaporated to dryness under vacuum. The residue, showed 
only one spot by t.l.c. in two solvent systems.
R^. in solvent system (l) = 0.20.
R^  in solvent system (2) = 0.55*
The ultraviolet absorbing spot on the thin layer plate gave a 
yellow colour when sprayed with 2,4“dinitrophenylhydrazine reagent.
£
N -Hydroxyadenosine 5'"diphosphate
6-Thioinosine 5'""diphosphate (150 mg) was dissolved in water (10 ml). 
A solution of sodium sulphite heptahydrate (1.7 g) and sodium bisulphite 
(0.3 g) in water (5 ml) was added over a period of 5 hours. Air was 
bubbled through the solution for 2 days. The reaction was followed by 
loss of the 320 nm chromophore.
The ultraviolet spectrum at pH 6.5 showed X = 274 nm»nisix
When the reaction was complete a solution of hydroxylamine
hydrochloride (l g hydroxylamine hydrochloride in 5 ml water adjusted
to pH 7.0 with sodium hydroxide) was added and left for 6 hours at room
temperature. The reaction was followed by a change in the ultraviolet
absorption maximum from 274 nm to 266 nm. The reaction mixture was
£
chromatographed on DEAE-Sephadex. N -Hydroxyadenosine 5'"diphosphate
was obtained as a pale blue solid. The product was dissolved in
water (10 ml) and eluted from a Chelex 100 (H+) column with water.
After passage through a column of Dowex 50 (Na+) the sodium salt was
obtained as a white solid in an overall yield of ’JQffo of theoretical
as determined by ultraviolet absorption.
The ultraviolet spectrum at pH 6.5 showed X = 266 nm (€ = 13,800).max
in solvent system (l) = 0.10
R^  in solvent system (2) = 0.20
The product contained 2.05 moles of phosphorus per mole of 
nucleotide as determined by organic phosphate analysis.
£
Poly N -hydroxyadenylate
Sodium N -hydroxyadenosine 5 '“diphosphate (6 mg) was dissolved
2+in a buffer (0.3 ml) containing tris-HCl -(200 mM), Mg (13.3 mM) and 
EDTA (6.7 mM) • at pH 9«0« Polynucleotide phosphorylase from M. luteus 
was added (0.1 ml, 7*5 units) and incubated at 37° for 10 hours. The 
course of the reaction was followed by inorganic phosphate release.
Cold aqueous phenol (4 ml) was added and shaken vigorously. The 
phenol layer was removed and the extraction repeated with fresh aqueous 
phenol (4 ml). The combined phenol layers were backwashed with water. 
The|combined aqueous layers were dialysed for 16 hours at 4° against 
an aqueous solution of sodium chloride (0.1 M) and EDTA (l mM). The 
dialysis was continued for a further 24 hours against two changes of 
distilled water. The product was obtained as a white solid after 
lyophili sation.
The ultraviolet spectrum at pH 6.5 showed X = 267 nm« Themax
extinction coefficient determined by phosphate analysis was 9»200.
Formamide gel electrophoresis gave an S^ q ^ of 12 S.
Hybridisation of poly N “hydroxyadenylate
Solutions of the polynucleotides were made up according to the 
method of continuous variations (Job, 1928). The ultraviolet 
spectrum of each solution was recorded after standing for 6 hours at 
25° or as described in the results and discussion section.
Phosphorolysis of poly N -hydroxyadenylate
Poly N^ -hydroxyadenylate (l un:^ ) was dissolved in buffer (l ml)
containing Mg^+ (10 mM), EDTA (5eM), tris- HC1 pH 8.5 (150 mM) and 
phosphate (500 mM). A solution of polynucleotide phosphorylase in 
water (lOjUl, 0 •75 units) was added and incubated at 57°• -he reaction
was followed by ultraviolet absorption at 266 nm.
£
Enzymatic degradation of poly H -hydroxyadenylate 
£
Poly N “hydroxyadenylate (l was dissolved in 0.05 M
sodium acetate pH 6.0 (l ml) and equilibrated for 50 mins. at 57 • A 
solution of ribonuclease in water (lO/il, 8 units) was added. The 
ultraviolet absorption at 266 nm was followed. After 2Q .hours the 
digestion was complete.
Treatment of the product with bacterial alkaline phosphatase and 
subsequent t.l.c. showed one spot with an corresponding to N^ “ 
hydroxyadenosine.
6 6 N “Methyl“N “hydroxyadenosine
6 6N “Methyl”N “hydroxyadenosine was prepared from 6“thioinosine by
£
a method identical to the synthesis of If “hydroxyadenosine. 5 diphosphate 
from 6-thioinosine 5'“diphosphate. N“Methylhydroxylamine was used in 
place of hydroxylamine. The product was recrystallised from water in 
a yield of 80$ of theoretical.
The ultraviolet spectrum at pH 6.0 showed A = 279 urn (£ 14,850)
UlclX
RESULTS AM) DISCUSSION
Attempts to chemically phosphorylate the commercially available
£
N “hydroxyadenosine with phosphorus oxychloride in a pyridine, formic
acid, methyl cyanide mixture (Strobach, 1969) were unsuccessful. The
reaction resulted in a complex mixture of products which could not be
satisfactorily resolved on DEAE-Sephadex nor identified by ultraviolet
spectroscopy or thin layer chromatography. Inorganic phosphate
co-chromatographed with the majority of the ultraviolet absorbing
material. Prior removal of the phosphate by precipitation with lithium
hydroxide did not simplify the chromatographic profile.
An alternative procedure, to chemically modify a pre-formed
nucleoside diphosphate, was investiaged. H^ -Hydroxyadenine has
previously been synthesised from 6-chloropurine by treatment with
hydroxylamine (Giner-Sorolla and Bendich, 1958; Giner-Sorolla, 1970)•
£
The N -hydroxyamine group has also been introduced into purines via
the sodium salt of the 6-sulphonic acid (Giner-Sorolla and Burchenal, 1971)*
The latter is easily prepared by a substitution reaction from the correspondin
6-chloro compound (Giner-Sorolla and Burchenal, 1971) or by oxidation of
6“thioinosine (Rackwitz and Scheit, 1974)*
Experiments with 6-chloropurine 9"p “D“riboside were often
complicated by its instability in alkaline solution. Consequently,
£
the preferred starting material for the synthesis of N -hydroxyadenosine
5 '-diphosphate (9) was 6“thioinosine (5) (Fig. 5). The chemical
£
•modification of the 6“thio compound to the N “hydroxyamine. compound was 
investigated at the nucleoside level and found to proceed almost 
quantitatively as judged by ultraviolet spectroscopy and thin layer 
c hromatography•
Phosphorylation of 6“thioinosine (5) with phosphorus oxychloride 
in a pyridine, formic acid, methyl cyanide mixture (Strobach, 1969) 
gave the desired 6“thioinosine 5 '“monophosphate (6) in 80$ yield. There 
was no trace of 5'“monophosphate. The reactive species in the 
phosphorylation reaction is probably the trichloropyrophosphopyridinium 
chloride (10) described by Sowa et al, (1975) (Fig. 3). The size of 
this species and the acidity of the solution are thought to be responsible 
for its selectivity at the 5*"position of a nucleoside.
6-Thioinosine 5 '"diphosphate (7) was prepared from the 5*" 
monophosphate (6) in a yield of 60$ by the imidazolide method of 
Cramer and Heunhoffer (1962). The 2'and 3' vicinal hydroxyl groups
FIGURE 3
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Synthetic route to N -hydroxyadenosine 5'“diphosphate
(5) 6-thioinosine
(6) 6-thioinosine 5'"monophosphate
(7) 6-thioinosine 5'-diphosphate
(8) purine 6-sulphonic acid 9“£“U- riboside
5'-diphosphate 
£
(9) R “hydroxyadenosine 5'“diphosphate
(10) trichloropyrophosphopyridinium chloride
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were shown to be unreacted by the successful preparation of the
2', 3'“iso-propylidene derivative and by periodate oxidation to the
dialdehyde. 6“Thioinosine 5'“diphosphate (7) was converted to the
sodium salt of purine 6-sulphonic acid 9~£ “D“riboside 3'“diphosphate (8)
6and then to N -hydroxyadenosine 5'“diphosphate (9) in an overall yield
after chromatography of ICffo.
The latter was isolated as a pale blue solid and the colour was
thought to be due to the presence of traces of iron as a ferric ion
complex. A solution of N “^hydroxyadenosine was mixed in various
ratios with an equimolar solution of ferric chloride in 0.05 M sodium
acetate buffer at pH 6.0. After standing at room temperature for several
hours a permanent blue colour developed with a visible absorption
maximum at 540 nm; the intensity of which corresponded to a 1:1 complex.
6The visible absorption maximum of the pale blue N -hydroxyadenosine 5'“ 
diphosphate was also 540 nm.
g
The N -hydroxyadenosine 5'“diphosphate was characterised by 
"ultraviolet absorption and phosphate analysis. Treatment of the 
compound with bacterial alkaline phosphatase gave one spot on thin
g
layer chromatography corresponding to authentic N -hydroxyadenosine.
Determination of the pKa&.of 1^ -hydroxyadenosine was carried out 
by following the change in the ultraviolet absorption with pH (Pig. 4)*
The values, calculated graphically, were p.Ka^  = 2.85 and p.Ka^  =10.2.
The latter figure is only approximate since at pH values above 10 the 
ionisation is accompanied by a gradual degradation. The products of 
degradation, which do not revert to N -hydroxyadenosine upon neutralisation, 
probably include 6,6-bis (azoxypurine-9“£-D-riboside) (Giner-Sorolla, 1970).
The pale blue N^ -hydroxyadenosine 5 '“diphosphate was a poor substrate 
for polynucleotide phosphorylase from M. luteus. The polymerisation was 
followed by inorganic phosphate release and showed a lag phase of about 
five hours (Pig. 5a). The lag phase could be reduced to 2 hours by 
including a trace of an oligonucleotide primer in the reaction. This 
has the effect of overcoming the rate-limiting initiation step. However 
even under these conditions only 15/& of the monomer was incorporated into 
polymer. The possibility that ferric ions were responsible for the low
FIGURE A
N -hydroxyadenosine: p.K determination_____________________a____________
6N “hydroxyadenosine (5*0»D2^^ ) was dissolved in water 
(10 ml). The p.H was adjusted by addition of 
micolitre quantities of either concentrated acid or 
alkali. After each addition the ultraviolet 
spectrum was recorded. The graph records the change 
in the absorption at 266 n.m with the change in pH 
of the solution.
The value corresponds to the mid-point 
between two adjacent horizontals. 
p.Ka^  = 2.8
p.Ka^  = approx. 10.2
figure 4
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FIGURE 5
Polymerisation kinetics for N "hydroxyadenosine 
5'-diphosphate
a) The polymerisation contained the 
a total volume of 0.4 mls- 
N6-OHA3)P 
Mg2+
EDTA
Tris-HCl pH 9.0 
PNPase
Incubation was performed at 37° •
Pale-blue N6-OHADP 
Pale-blue N^ -OHADP + Primer 
White N6-OHADP
b) The incubations were performed as above but
using varying concentrations of white 
£
N -hydroxyadenosine 5'“diphosphate. The
initial velocity was calculated over the 
first ten minutes.
following in
30 mM 
10 mM 
5 niM 
150 mM 
7*5 units
■ isH hi
time/hrs
yield of polymer was investigated by their prior removal.
g
N -Hydroxyadenosine 5 '“diphosphate was passed through a column of
Chelex 100 in the hydrogen ion form. 97$ of the total nucleotide eluted
with water and on evaporation to dryness yielded a white solid. The
remaining 3$ was eluted with ammonium hydroxide as a deep blue solution.
The white N -hydroxyadenosine 5'“diphosphate was converted to the sodium
salt and polymerised as before. 55$ Of the monomer was incorporated into
polymer as observed by inorganic phosphate release (Fig. 5a). The
kinetics of the polymerisation showed no lag phase. A graphical plot
of initial rate versus substrate concentration enabled the estimation
of the kinetic constants (Fig. 5^ )* They were found to be Km = 13«3niM
and V Y = 0.48^ umole/0.4 ml/hr.
The size of the poly N^ -hydroxyadenylate was determined under
denaturing conditions on a formamide slab gel at 60°. (Pinder et al, 1974)*
By comparison with known molecular weight markers the most densely stained
region corresponded to material with a sedimentation coefficient,
Son of 12 S.20,w 6
The ultraviolet absorption spectrum of poly N -hydroxyadenylate acid
shows a maximum at 267 nm (C 9>200) as (Fig. 6). The spectrum of"' 
poly N -hydroxyadenylate is unchanged at all pH values between pH 5*0 
and pH 9»0. Below pH 5*0 and above pH 9«0, precipitation and 
degradation respectively begin to occur, and it is not possible to measure 
p.K values.
a 6 For the purposes of the structural determination of poly N ~
hydroxyadenylate (ll) (Fig. 7) it is useful to make comparisons with the
structures of two closely related polyribonucleotides, polyadenylate (12)
and poly N^ -hydroxyethyladenylate (13) (Van Holde et al, 1965).
Polyadenylate forms a protonated double^ stranded helix at pH values
below 5*79- This p.K value is over 2 units higher than the p.K value
& cl
for adenosine which is 3.83. On the other hand, the steric size of the 
£
N -hydroxyethyl group is thought to be responsible for the lack of 
double-stranded complex formation for poly N -hydroxyethyladenylate at 
all pH values. This is reflected in the P»Ka values which are very 
little different between the polymer (3«40) and the nucleoside (3*53)*
FIGURE 6
Ultraviolet absorption spectrum of o61y
6 6 N -hydroxyadenylate and IT -hydroxyadenosine
The spectra were recorded in water at pH 5«5«
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FIGURE 7
Chemical structure of some derivatives of polyadenylate 
£
(11) poly N -hydroxyadenylate
(12) polyadenylate
£
(13) poly N -hydroxyethyladenylate
figure 7
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By comparison, it would be expected that if poly N “hydroxyadenylate 
were to form a protonated double-stranded helix then the p.k value of
Si
the polymer would be similarly increased relative to the nucleoside,
bringing it to about pH 5«0. Since there is no indication of a change
6in the . ultraviolet absorption of poly N -hydroxyadenylate down to — ■
pH 5*0 it is unlikely that the polymer forms an analogous complex,
£
The degree of secondary structure exhibited by poly N -
hydroxyadenylate in solution was investigated by enzymatic degradation.
The polymer was resistant to attack by snake venom phosphodiesterase,
spleen phosphodiesterase, ribonuclease Tn and pancreatic ribonuclease.
6However, poly N -hydroxyadenylate was phosxhorylised by polynucleotide
6phosphorylase at pH 8.5 to yield N -hydroxyadenosine 5'“diphosphate, the
hyperchromic shift at 267 nm being 40$« Under the conditions employed
(high ionic strength, high pH and 37,(>) some precipitation and modification
of the base occurred. At a slightly acid pH the polymer was a substrate
for ribonuclease T0. This enzyme, which is purine specific, has an
6optimum pH at 4*5 and, as expected, poly N -hydroxyadenylate was degraded 
faster at pH 5*0 than at pH 6.0 (Table l). Polyadenylate displays an 
apparently anomalous behaviour since it is degraded faster at pH 6.0. 
However, this can be explained by the presence of a protonated double­
stranded helix at pH 5*0 and lends further evidence to the argument against 
poly N -hydroxyadenylate acid forming an analogous complex.
The hyperchromic shift on ribonuclease digestion of poly N - 
hydroxyadenylate was 53$» This figure suggests a high degree of stacking
between neighbouring bases in the polynucleotide chain and is similar
£
to the 50/6 observed for poly N “hydroxyethyladenylate.
The stability of the stacking interaction was investigated by 
heating a solution of the polymer. The plots of ultraviolet absorption 
versus temperature (Fig. 8) exhibited a co-operative change of about 33$ 
at all pH values. Such a co-operative melting is normally associated 
with a double-stranded, hydrogen-bonded complex except that the previous 
evidence does not support this structure for poly N -hydroxyadenylate.
From model building studies it is possible to construct a stacked dimer 
in which the hydrogen atom of an N -hydroxyl group is hydrogen-bonded
7
to the N of the adjacent base. This arrangement in the polymer may
give rise to the observed co-operative melting profiles (Fig. 8).
£
The overall structure of poly N “hydroxyadenylate can be clarified
TABLE 1
Degradation of ooly(A) and ooly(N^ -QHA) by 
ribonuclease
£
Equimolar solutions of poly(A) and poly(N -OHA) 
were made up in the following buffers and incubated 
with ribonuclease Tg at 37°•
1) 0.05 M sodium acetate pH 6.0
2) 0.05 M sodium acetate pH 5*0
The figures in the table are arbitrary but represent 
the relative initial rates of degradation.
TABLE 1
pH 5 pH 6
poly (A) 130 200
poly(N6-OHA) 1.9 1.0
FIGURE 8
Thermal melting of poly N -hydroxyadenylate
The solutions contained poly N -hydroxyadenylate 
(l A 26y/m )^ 0.15 M sodium chloride and 0o01 M
cacodylate buffer at pH5, pH6 and pH7.
At pH8 and pH9 the buffer was 0.01 M tris-HCl
Tm 
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by comparison of the circular dichroic spectra with that of known 
compounds (Fig# 9)* Foly IT “hydroxyadenylate acid shows a positive 
peak with a maximum at 279 nm ( Q * « 68,000) and a negative peak with a 
minimum at 254 nm (6 ' = “96,900). The circular dichroism is cancelled 
at 266 nm. The relative intensities of the peaks are similar to the 
neutral form of poly (A) and also of poly (IT -HEA), both of which are 
single-stranded. The double-stranded form of poly (A) in acid solution 
gives a different shaped curve (Fig. 9)*
It would appear therefore that poly (N -0HA.) exists in a single­
stranded stacked structure which may be stabilised by intramolecular 
forces, such as hydrogen bonding between vertically adjacent bases.
The induction of interferon requires a double-stranded complex
£
between two polyribonucleotides. The possibility of poly N -
hydroxyadenylate forming such a complex was investigated by standard
mixing curve techniques (Job, 1928). No hybridisation was observed
with polyadenylate, polyuridylate, polycytidylate, polyguanylate,
polyinosinate nor poly 5"bromouridylate, under a wide range of
conditions. Mixtures of poly N “hydroxyadenylate and polyxanthylate
showed no hybridisation at pH values 7*6 and 6.8. However, polyxanthylate
has two apparent P»Ka values at 5*72 and 7«34 and thus under the described
conditions the xanthine base residues are ionised. At pH 5*3 where the£
base residues are electrically neutral, heating a mixture of poly N - 
hydroxyadenylate and polyxanthylate above 49° caused a small hypochromic 
shift in the ultraviolet absorption at 265 nm (Fig. 10). Both poly 
N^ -liydroxyadenylate alone and polyxanthylate alone showed a large 
hyperchromic shift at the same wavelength. This indicated that there 
is an interaction between these two polymers. Apparently, it is necessary 
to first melt the polyxanthylate before this interaction will occur, 
since a solution of the two polymers kept at 46° for several hours does 
not show a hypochromic shift whereas one kept at 52° does. This 
temperature is well below the Tm of poly IT “hydroxyadenylate but is just 
above the Tm of polyxanthylate, at 48°• The complex was shown to have 
a lsl stoichiometry by construction of mixing curves (Fig. ll). It 
could not be prepared in a solution of low ionic strength (0.05M), 
behaviour characteristic of double-stranded hydrogen-bonded complexes 
which need higher ionic strengths to stabilise the complex by reducing 
repulsion between ionised phosphate groups.
FIGURE 9
Circular dichroism of poly N^ -hydroxyadenylate 
compared with poly (A) and poly (N -HEA)
6
Poly N “hydroxyadenylate acid was made up at 0.22 mg 
in a solution containing 0.15 M NaCl and 0.01 M 
cacodylate buffer pH 7*4
a -a— a  poly N “hydroxyethyladenylate
(Van Holde et al, 1965)
polyadenylate pH 4*9
(Van Holde et al, 19&5) 
poly N “hydroxyadenylate
polyadenylate pH 7*4
(Van Holde et al, 1965)
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FIGURE 10
Variation in the ultraviolet absorption -with 
temperature for ooly (N -OHA.) and poly(x)
Equimolar solutions of polynucleotides were made 
up in a buffer containing 0*15 M Had and 
0.01 M cacodylate at pH 5-3« The variation of 
ultraviolet absorption with temperature was 
followed.
Poly (N -OHA)
Poly (X)
Poly (N6-0HA) + Poly (x) 1
£x
10
"
figure 10
«
IQ-
20 80
temperature/°C
FIGURE 11
Mixing curve for the interaction between 
noly (N^ -OHA.) and noly (x)
Various ratios of the two polymers were mixed in a 
buffer containing 0.15 M NaCl and 0.01 M cacodylate 
at pH 5»5« The ultraviolet absorption spectrum 
was recorded after heating the solution to 80° 
and re-cooling.
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Heating a solution of the complex resulted in a single, 
co-operative hyperchromic shift beginning at about 90° (Fig.10).
The Tm is presumably above 95° which is too high to be measured 
accurately. The hyperchromic shift up to 95° was 27$ whereas it 
would be expected from the hyperchromic shift of the unassociated 
polymers that the total hyperchromicity should be about 45$.
Raising the pH of a solution of the complex resulted in a 
rapid loss of the structure presumably as a result of ionisation of 
the polyxanthylate base residues. At pH 6.5 the melting profile 
was equivalent to the sum of the two components. The hypochromicity 
of the complex calculated from the mixing curve is 11.5$.
Further evidence for the formation of the complex at pH 5*2 
came from the rate of degradation by ribonuclease T^ > which was 
much slower than the rate for the component polyribonucleotides (Table 2).
An insight into the structure of the hydrogen-bonded complex 
6between poly IT -hydroxyadenylate and polyxanthylate can be gained 
by determination of the tautomeric form of N -hydroxyadenosine.
The question concerns the IT -hydroxyamine group which may exist 
as either the amino (14) or imino (15) tautomer (Fig. 12).
One method, first used in the heterocyclic field by Tucker 
and Irvin (l95l)> involves determination of p.K values. The£L
dissociation constants K^ , K^ , and K^  shown in figure 12 can be 
related by the following formulae:-
K, = K. + Kg1 A 
-
KA
providing that the site of protonation is the same for both tautomers
and is at the position shown in the figure. This was verified by
N.M.R. spectroscopy (Table 5) which, under acid conditions, showed a
similar C(8)H chemical shift for related compounds in the amino and
imino tautomeric forms.
Kn is found to be 1.41 x 10 ^ from the p.K value of 2.85 for
N -hydroxadenosine. If it is assumed that replacement of the 
6N -hydrogen atom by a methyl group in the amino tautomer has only
a small effect on the dissociation constant, then the experimentally
6 6determined p.K value of 5*5 for IT -methyl-N -hydroxyadenosine gives &
TABLE 2
Degradation of poly (IT -OHA). poly (x )
Equimolar solutions of the polyribonucleotides were 
made up in a buffer containing 0.15 M NaCl and 
0.05 M sodium acetate at pH 5*3. Ribonuclease T  ^
(7 units) was added and incubated at 57°•
The change in ultraviolet absorption with time was 
followed. The time taken to reach half of the 
total hyperchromic shift was recorded.
TABLE 2
POLXMER Time/mins. Hyperchromicity
poly(N6-OHA) 60 53$
poly(x) 10 25$
poly(N^ -OHA.)+ poly(x) 35 42$
poly (N^ -OHA.).poly(x) 150 72$
FIGURE 12
Chemical structure of some nucleosides
£
(14) amino tautomer of N -hydroxyadenosine
(15) imino tautomer of N -hydroxyadenosine
(16) adenosine
(17) l~methyladenosine
6 6(18) N -methyl, N -hydroxyadenosine
(14)
R K,
K\
R
/  (15) 
* K B
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R
R
H3C\n/0H (17)
TABLE 5
Observed chemical shifts
The chemical shifts were measured in d^ -BMSO
solution and are expressed in Hertz downfield from
internal tetramethylailane.
The c(8)-H and C(2)“H protons were distinguished
by comparison with literature values (Evans and
Sarma, 1974)* A and 1-MeA represent extremes in
the amino“imino tautomer equilibrium. By inspection
£
the values of the chemical shifts for N -OHA and 
6 6N “Me,N -OHA are probably as shown. c
For N -OHA 471 Hz is too low to be due to
the c(8)“H proton unless it is due to an inductive
£
effect of the hydroxyl group on the N position.
6 6Such an effect is absent in N “Me,N -OHA.
6 6N “Me,N -OHA is constrained to the amino 
form and the C(8)-H proton should have a value 
similar to that for A. The value of 504 Hz is 
therefore probably the C(8)“H proton chemical shift.
TABLE 5
COMPOUND
CHEMICAL SHIFT/Hz
C(8)H C(2)H C(8)H + L+
A 502 492 525
1-MeA 478 482 524
n6-oha 486 471 527
N6-Me,N6-OHA 504 494 528
an approximate value of 0.316 x 10 for L, Substituting these
Jx •
figures in the above equations gives a value of 3*47 for Thus
the imino tautomer of N -^hydroxyadenosine appears to be predominant 
(78ic).
An alternative method involving N.M.R. spectroscopy can be used
to determine the tautomeric form since the amino form has more aromatic
character than the imino form. Three reference compounds were useful
for comparison; adenosine (16) (Fig. 12) which is known to be in the
amino form, 1-methyladenosine (l7)> which is restricted to the imino
tautomer, and N^ -methyl-N^ -hydroxyadenosine (18) which is restricted to
the amino tautomer. The c(8)fi proton is ideally situated for this
study since it is distant enough not to be affected by the various
functional groups, but only by the aromaticity of the ring system
(Evans and Sarma, 1974). The chemical shifts are shown in table 3«
If a linear relationship is assumed to exist between the percentage
of a given tautomer present and the chemical shift of the c(8)-H
proton, it may be inferred that the contribution of the imino form
is 66$ of the total.
It is very difficult to draw a satisfactory hydrogen bonding
scheme between poly N -hydroxyadenylate in the imino form and the
neutral form of polyxanthylate.
The hydrogen-bonding properties of hydroxyad enosine are of
possible importance to the study of hydroxylamine mutagenesis.
Hydroxylamine is a strong nucleophilic reagent and its mutagenic
activity is thought to be mainly due to its reaction with cytidine
residues and possibly to a smaller extent adenosine residues in
nucleic acids. The product of the reaction with adenosine is 
£
N -hydroxyadenosine (Budowsky et al, 1969; Budowsky et al, 1971;
Brown and Osborne, 1971)» v/hich is generally regarded as being
non-mutagenic. This would imply that the amino form predominates 
£
with the N -hydroxyl group anti to the ring N(l), since this 
arrangement allows unchanged base pairing with uridine or thymidine 
(Fig. 13). However, there is evidence that the action of hydroxylamine 
on plage T4 in vitro may result in A-+G transitions (Ripley and Brake,
1972) which can only arise by normal Watson-Crick base-pairing if
6 6 N -hydroxyadenosine is in the imino form, again with the IT -hydroxyl
FIGURE 15
£
Hydrogen bonding schemes for N -hydroxyadenosine
figure 13
HO
HO
HO
x =  h ,ch3
HO
group anti to the ring N(l) (Fig, 13). It may he that 
£
N -hydroxyadenosine has an ambiguous, dual functional activity,
an inference which is supported by the result presented in this
chapter, that the ratio of imino to amino tautomers is only about
62:1. The related compound, N -methoxyadenosine is also largely
in the imino form (Simukova et al, 1975).
By comparison with 5"*substituted N^ -hydroxycytidine (Shugar
7 6et al, 1976), steric hindrance between N and the N -hydroxyl group
would be expected to favour the conformation with the hydroxyl
group syn to N^ . As normal Watson-Crick hydrogen bonding is not
possible with this conformation it could explain the lack of complex
formation of poly N^ -hydroxyadenylate.
£
When IT- -methoxyadenosine residues were used either in the
template or as precursors in an RITA polymerase system no functional
activity was detected (Budowsky et al, 1975).
The conclusions drawn from these apparent contradictions are 
£
that N “hydroxyadenosine exists predominantly in the imino form with 
the N -^hydroxyl group syn to There are precedents for non-hydrogen
bonding bases exhibiting a specific functional activity in polymerase 
enzyme systems. For example, a copolymer containing cytidine and 
3”methylcytidine acted as a template for RITA polymerase and directed 
the incorporation of guanosine and uridine into the complementary 
strand (Ludlum and Wilhelm, 1968; Ludlum, 1970). Since it is not 
possible to draw a satisfactory hydrogen bonding scheme between 
3”methylcytidine and uridine, one explanation may be that uridine is 
incorporated because it is the least bulky of the possible substrates.
g
A similar argument may be applied to IT -hydroxyadenosine, causing 
a variable conformational specificity between different biological 
systems.
BIOLOGICAL ACTIVITY
One of the requirements for a polynucleotide interferon inducer 
appears to be the presence of a double-stranded complex (DeClercq, 1974)*
g
The complex formed at pH 5*3 between N -hydroxyadenylate and 
polyxanthylate was not stable under the conditions required to perform 
an interferon induction assay (ie pH 7*5 and 0.15 M Na+). However, the 
single-stranded polymer was tested for activity in two other biological 
systems.
Both poly (i) and poly (c) have been shown to possess in vivo
antiviral activity in mice against EMCV (Stebbing et al, 1976a).
Although it is thought that the effect is by blocking or competing
with the poly (c) region within the viral genome, this is by no means
proven. At this stage any single-stranded polynucleotide may be
a potential antiviral agent in this system.
6Poly N -hydroxyadenylate was made up in 0.89$ (w/v) NaCl and
10 mM HEPES buffer at pH 7 - 5» to a concentration of 4nig/ml. 100
of this solution was injected intraperitoneally or intravenously into
LACA mice at 6 hours before infection with a 1 x LD dose of EMCV.
6 -LUU
Poly N -hydroxyadenylate conferred no significant protection
to the mice. Under identical conditions poly (i) and poly (c) were
significant to the confidence level of 99$«
CHAPTER 2
COPOLY (INOSINATE, 6-THIOINOSINATE)
INTRODUCTION
Reasons for modification of the polyinosinate strand of the 
interferon inducing complex, poly ( i ) .  poly (c)  were introduced in 
the previous chapter. Substitution by a sulphur atom in the 6- 
position of inosine can be expected to have a significant effect on 
the biological properties of the complex, since this position is an 
obligatory hydrogen-bonding site. Substitution of oxygen by sulphur 
generally leads to a decrease in hydrogen bonding strength, because 
of the increased Van der Waal's radius and the decreased electro­
negativity (Donohue, 1969). Substitution by sulphur offers two 
potential advantages. Firstly, it has been shown that sulphur- 
containing molecules are 'sticky' for proteins, probably by the 
formation of covalent disulphide linkages (Bardos et al, 1973;
Sawada, 1975)* This could be of particular advantage when considering 
antiviral mechanisms such as the inhibitions of polymerase enzymes. 
Secondly, sulphur is a very versatile substituent and it is possible 
to synthesise a wide variety of polymers by various reactions at this 
position.
6-Thioinosine shows tumour growth inhibitory properties in 
animals and has been tested against a variety of human neoplasms 
(Farber et al, 1956). The mechanism of action is thought to be 
by inhibition of protein synthesis (Lea, i960). The 5'-diphosphate 
of 6-thioinosine was claimed to be a potent inhibitor of polynucleotide 
phosphorylase from M. Luteus (Carbon, 1962). The E.coli enzyme was 
found to be less sensitive and a low percentage of 6-thioinosine 
nucleotides were incorporated into poly (a) (Cardeilhac and Cohen, 1964)*
At the outset of the work presented in this chapter, it was hoped 
to overcome the problem of low incorporation, and to enzymatically 
synthesise a co-polymer containing a high percentage of 6-thioinosine 
nucleotides. However, since then, a publication has appeared on the 
enzymatic synthesis of a copolymer containing inosine and up to 24$ 
of 6-thioinosine (llchic et al, 1973)* The findings reported here are 
in general agreement with those of Uchic et al although a few significant 
differences are noted. More recently, poly 6-thioinosinate has been 
prepared by the chemical thiolation of poly 6-chloropurine (Uchic et al, 
1974; Broom et al, 1976).
EXPERIMENTAL
Inosine 5 '“diphosphate was obtained from P”K, Bio'chemicals 
Copoly (inosinate, 6-thioinosinate)
The sodium salts of 6-thioinosine 5'“diphosphate and inosine 
5'-diphosphate were mixed in various ratios and dissolved in buffer 
to give as the final composition:-
S6ZDP + ILP 30mM
MgCl2 lOmM
EDTA 5mM
Tris/HCl pH 9.0 150mM
Polynucleotide phosphorylase 20 units/ml.
Polymerisations were carried out at 35° for 6 hours and were 
followed by inorganic phosphate release.
Purification of the polymers was carried out as previously 
described.
Analysis of Copoly (inosinate, 6-thioinosinate)
Approximately 100yug of polymer was dissolved in a buffer (l ml)
containing 0.05 M tris pH 7*5• This was transferred to a cuvette
and degraded by the action of T^ ribonuclease (5 jULg) and bacterial
alkaline phosphatase (5/*g)» Cta complete digestion, as observed
by ultraviolet absorption, the optical density at the A, of themax
two nucleotides was recorded. The ratio of nucleotides in the polymer 
can be calculated from the formula:-
I A x C  ^ 1 - A x f  ^_2__ = 250 320___________ 520 vL 250
SI A320 x G  250 ~ , A250 x 6320
S /" I
Since the extinction coefficients ^  an<^  ^  ^20 are
relatively small the formula can be simplified without introducing
much error.
r  s6'1
1 _ 250 x C  320
S 1 A320 X 6  250
Hybridisation studies with copoly (inosinate, 6-thioinosinate)
Equimolar solutions of copoly (inosinate, 6-thioinosinate) and 
polycytidylate were made up in a buffer containing sodium chloride 
(0.15M) and sodium acetate (0.05M) at pH 7*0. Various mixtures were
made up according to the method of continuous variations (Job, 1928). 
After 2 hours at room temperature their ultraviolet spectra were 
recorded.
RESULTS AND DISCUSSION
6"Thioinosine 5 diphosphate was synthesised by chemical 
phosphorylation of the commercially available 6-thioinosine. The 
overall yield after chromatography was 34$ of theoretical as determined 
by ultraviolet absorption. ^
No polymerisation of 6-thioinosine 5'“diphosphate with poly­
nucleotide phosphorylase from M. Luteus or from E. coli was detected 
by phosphate release or thin layer chromatography. This was true 
at both pH 9.0, the usual pH for this reaction and also at pH 7*5 
where the 6-thioinosine bases are not ionised (p.K of 6-thioinosine 
3'“diphosphate is about 7«8)« Despite the original report (Carbon, 
1962) it proved possible to synthesise a copolymer with inosine 
5'"diphosphate as the other substrate (table 4)« The enzyme used 
in these experiments was from M. luteus although the E.coli enzyme 
gave essentially the same ratio of incorporation for the two bases. 
6-Thioinosine 5'"diphosphate is not as good a substrate as inosine 
5'“diphosphate; inosinate is preferentially incorporated into polymer 
and increasing the ratio of 6-thioinosine 5'"diphosphate in the reaction 
mixture decreases the yield of polymer. Uchic et al (1973) reported 
that the highest level of incorporation of 6-thioinosine that they 
obtained in a reasonable yield was 24$. Results presented here show 
that it is possible to obtain 67$ incorporation and still obtain a 
good yield. The polymer containing the highest ratio of 6-thioinosine 
residues, poly (I, S I^) must contain adjacent thiolated bases. Thus 
it is possible for polynucleotide phosphorylase to join at least two 
6-thioinosine nucleotides together, although it is probably a very 
slow process.
By analogy with polycytidylate (Hochberg and Keren-Zur, 1974) 
polyadenylate might be expected to yield poly 6-thioinosinate by 
treatment with liquid hydrogen sulphide. However, only 10$ conversion 
was detected under identical conditions.
£
The molecular weights of the copoly (I, S I) samples were 
estimated, by comparison with known markers, by electrophoresis on 
3$ polyacrylamide gels. From an ultraviolet densitometer scan each
TABLE 4
Copolymerisation of inosine 5'“diphosphate with 
6“thioinosine 5'“diphosphate
The solutions contained the following components
S6IDP + LDP 30 mM
MgCl2 10 mM
ELTA 5 mM
Tris/HCl pH 9.0 150 mM
PNPase 20 units/ml.
Incubation was carried out at 35° for 6 hours.
The percentage polymerisation is calculated from 
the weight of the isolated polymer.
TABLE A
6 6 
*fo S IBP in $ S IMP in $ polymerisation
substrate polymer
100 -  0
83 67 15
50 33 30
17 8 35
4 2.5 46
0 0 40
polymer was observed to have a peak of absorption with a mobility
corresponding to an SgQ of about 10 S. There was a very slight
trend towards a lower mobility as the 6-thioinosine content increased,
but this could be due to secondary structure differences.
£
The secondary structure of the copoly (l,S i) samples was 
investigated by measurements of their hyperchromicity (table 5) •
The buffer solution chosen to make these measurements approximated 
to physiological conditions since it is in this state that the 
polynucleotides are used for in vivo biological assays. The 
thermal melting profiles were very broad and the results in the 
table record the overall thermal hyperchromicity over the temperature 
range from 20° to 90° • It has been reported that 6-thioinosine, 
particularly when incorporated into a polymer, is thermally labile, 
as indicated by a loss of the 320 nm chromophore (Uchic et al, 1974; 
Broom et al, 1976). However in the experiments described here this 
loss wa3 reversed on codling, suggesting that the effect is due to a 
pH shift on heating. The ultraviolet spectrum of 6-thioinosine is 
particularly sensitive to pH in this region.
Polyinosinate is a notoriously difficult polymer to work with 
and has been studied by a variety of physical techniques (Thiele 
and Guschlbauer, 1973; Cech and Tinoco, Jr., 1976). The structural 
evidence favours a single-stranded conformation in a solution of low 
ionic strength with a transition to a stable multistranded complex 
at higher ionic strengths and a mixture of the two at intermediate 
values. Two independent X-ray studies have concluded that the 
multistranded complex consists of four parallel strands with only 
the 0^  and atoms' hydrogen bonded (Arnott et al, 1974; Zimmerman 
et al, 1975).
The melting profile of poly (i) proved to be very dependent on 
the method of preparing the solution. Consequently, a standardised 
method was adopted involving heating solid poly (i) in buffer at 80^  
until it was completely dissolved and then cooling very slowly at room
TABLE 5
Physical characteristics of copoly(inosinate,
6-thioinosinate)
The thermal hyperchromicity values were measured 
in a solution containing sodium chloride (0.15 M) and 
phosphate buffer (0.05 M) at pH 7«5» Tbe values 
represent the change in the ultraviolet absorption 
at 250 nm over the temperature range from 20° to 90°•
The figure for poly (S I) is at 320 nm and is 
taken from Broom et al,(1976).
The total hyperchromicities are measured in the 
same buffer by digestion with T^  ribonuclease at 25°. 
The degradation was shown to proceed to completion by 
thin layer chromatography.
The extinction coefficients were measured by 
phosphate analysis.
TABLE 5
6io S I  bases Thermal Total Extinction
in polymer Hyperchromicity Hyperchromicity coefficient
100 40io
61 1^  31o 3450
33 11° 12fo 8650
8 2 io 15 °/o 10400
2.5 1 io \jfo 10500
0 2io (33$) 13$ 10500
temperature over a period of about 5 hours. The thermal hyper­
chromicity v/as then reproduceably found to be 2$ in 0.15 M Na+, The 
copoly (I,S^ l) samples did not show the same variation with protocol 
and were noticeably more soluble. It was found that even in copolymers 
with very low amounts of 6-thioinosine, the ability to form multi­
stranded complexes in high ionic strength solutions had been drastically 
reduced. For example, while poly (i) underwent a 21$ hyperchromic 
shift on heating in buffered 2 M NaCl, poly S^ l) only underwent
a 7i° shift.
At the other end of the scale, poly 6-thioinosinate is believed to 
exist as a two or more stranded helix (Broom et al, 1976) and exhibits 
40$ thermal hyperchromicity at its ^ max*
The currently accepted model for the four stranded complex of 
£
poly (i) has the 0 atoms of four inosine residues arranged around
the helix axis and separated by a distance of 0.282 nm (Amott et al,
1974) (Fig. 14)« The Van der Waalfs radius of sulphur (0.185 nm)»
which is larger than that of oxygen (0.140 nm) is too large for it to
replace one of the oxygen atoms. The tetrastranded helix has ten base
residues per turn in each strand. Thus, even for poly (l^» S I) there
would be about one sulphur atom in each turn of the helix. This may
6be the reason for the inability of poly S I) to form the multi­
stranded complex.
£
Unlike poly (i), poly (S i) does not form a double-stranded complex 
with poly (c) (Broom et al, 1976). The copolymers of inosine and 
6-thioinosine formed complexes of intermediate stability depending on 
the 6-thioinosine content (table 6).
FIGURE 14
Structure of the 4~stranded ooly(l) complex 
The figure is taken from Amott et al,(1974)
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TABLE 6
Physical -properties of the double-stranded complexes 
between noly(inosinate,6“thioinosinate) and 
nolycytidylate
£
Equimblar solutions of poly(lx,S I) and poly(c) 
were made up in a buffer containing 0.15 M sodium 
chloride and 0.05 M sodium acetate at pH 7*0. Equal 
volumes were mixed and allowed to stand at room 
temperature for 2 hours before recording the 
variation of ultraviolet absorption with temperature.
TABLE 6
/o S I bases Complex formation Co-operative hyperchromicity
in polymer with poly(c) melting temp on heating at
Tm/°C 250 nm
100 - - ■ - 
6?
33 + 60 391o
8 + 66 58^
2.5 + 67 62$
0 + 67.5 68$
BIOLOGICAL ACTIVITY
£
Solutions containing a mixture of poly (l,S I) and poly (c) were 
not assayed for interferon induction since the polymers with a high 
6-thioinosine content did not form a double-stranded complex under 
physiological conditions and also because it has been demonstrated 
previously that interruption of the homology of bases in one or both 
strands of a double-stranded interferon inducer may significantly 
reduce the interferon yield (Carter et al, 1972). However, since 
polyinosinate shows antiviral activity in mice against EMCY (Stebbing 
et al, 1976a), the copolymers of inosine and 6-thioinosine were 
assayed in the same system as described in Chapter 1.
The survival data of mice is presented in figures 15 and 16.
In all available base ratios poly (l,S I) was less protective than 
poly (i). Since the chemical nature of poly (i^S^l) and 
poly (lQ4,S6l) is virtually identical to poly (i) the loss in 
antiviral activity may be due to a change in the secondary structure 
upon thiolation. This effect is probably related to the lower 
thermal hyperchromicity displayed by these copolymers and supports 
the notion that it is the overall secondary structure which is
important rather than any effect due to binding with the viral genome.
6The copoly (l,S i) samples were also assayed against a viral 
reverse transcriptase as described in Chapter 6.
FIGURES 15 and 16
Survival data for EMCV infected mice treated with
various -polynucleotides
Polynucleotides were dissolved in 0.89/6 (w/v) 
sodium chloride and 10 mM HEPES buffer at pH 7»5 
to a concentration of 4 mg/ml. 100j&l of this 
solution was injected intravenously into BKW mice 
at 6 hours before infection with a 1 x ^ -j.00 ^ose 
of EMCV. Groups of about 20 mice were used for 
each treatment. The graph records the percentage 
survivors after a certain time in hours past 
infection. Records were made up twice daily.
Data supplied by N. Stebbing
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CHAPTER 5
P0LYXS0XA3CTHY1ATE!-
INTRODUCTION
The clinical value of poly (i). poly (c) is severely limited 
by its associated toxity (Absher and Stinebring, 1969)* Although
the cause remains obscure, the side-effects may be enhanced by 
persistance of the polynucleotides in the cellular environment.
A double-stranded polynucleotide which is more susceptible to enzymic 
degradation than poly (i). poly (c) would have less chance to exert 
its biological effects. Since interferon induction is a rapid 
event (Pitha els al, 1972) such a double-stranded complex may 
exhibit an improved therapeutic ratio by reducing the time available 
to exert its toxic side-effects.
Enzymes with a mode of action similar to pancreatic ribonuclease 
are found in a variety of animal tissues. Susceptibility to pancreatic 
ribonuclease in vitro is therefore a good guide to the general resistance 
of a polynucleotide in vivo. Pancreatic ribonuclease is an enzyme which 
can specifically cleave a phosphodiester linkage adjacent to pyrimidine 
nucleotides. Hence, in general, polypurine nucleotides are more resistant
 to.-degradation in vivo than polypyrimidine nucleotides. Only the poly (c)
strand of poly (i). poly (c) is degraded by pancreatic ribonuclease. The 
2-keto group of pyrimidines is important for the specificity of this 
reaction (Gassen and Witzel, 1967). It seemed possible that the poly (i) 
strand might be modified to increase its susceptibility to pancreatic 
ribonuclease whilst retaining its ability to hydrogen-bond with poly (0).
Polyisoxanthylate 6.9) (Fig. 17) is a polypurine with the same 
functional groups as poly (i) (20) and is therefore potentially capable 
of hydrogen bonding with poly (c). Displacement of the N-glycoside 
bond from the ’natural* position, as in polypseudouridylate (2l) or 
polyisoadenylate (22) has not lead to a profound change in their hydrogen- 
bonding properties compared with poly (u) or poly (A) (Pochon et al, 19645 
Michelson et al, 1966). Although poly (X) does not hydrogen-bond with 
poly (c) (Michelson and Monny, 1966) it cannot be argued that the same 
will apply to poly (iX).
Polyisoxanthylate can also be regarded as a 5»6“disubstituted 
derivative of poly (U) (23). Since it has a carbonyl group in 2-position 
adjacent to the N-glycoside linkage it may be accepted as a substrate 
by pancreatic ribonuclease.
FIGURE 17
Chemical structure of polyisoxanthylate and 
related polynucleotides
(19) polyisoxanthylate
(20) polyinosinate
(21) polypseudouridylate
(22) polyisoadenylate
(23) polyuridylate
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EXPERIMENTAL
Xanthine-3-j3 "D-ribofuranoside was obtained from Dr. C. Domfeld,' 
Searle Laboratories, Skokie, U.S.A.
Thin layer chromatography was carried out in the following solvent 
systems.
(1) i“propanol/ammonia/water ll:7i2
(2) 1 M Li Cl
Carrot nucleoside phosphotransferase --
Washed carrots (5 kg) were chopped and pulped in a liquidiser 
adding water as necessary. The juice (9 l) was frozen overnight.
After thawing it was centrifuged at 3,000 r.p.m. for 10 mins. The 
supernatant was spun at 15,000 r.p.m. for 30 mins. The clear solution 
(3l) was chromatographed on LEAE-Cellulose (15 g) previously 
equilibrated with 0.05 M sodium acetate pH 5*0 at 4°» The column was 
washed with 400 ml 0.05 M sodium acetate pH 5*0 and the protein then 
eluted with 0.4 M sodium acetate pH 5»0 at a flow rate of 1 Ml/min.
Fractions of 12 ml were collected and assayed for both phosphatase
and phosphotransferase activity as described below. The fractions 
containing the phosphotransferase activity were pooled (300 ml) and 
made up to 90/o saturation with ammonium sulphate (183 g). The 
solution was left over-night at 4°» and then centrifuged at 15,000 r.p.m. 
for 15 mins. The suspension of the sediment in water was dialysed 
overnight against water. The solution was made up to 0.05 M in sodium 
acetate at pH 5*0 and applied to a column of DEAE-Cellulose (2g) 
previously equilibrated with 0.05 M sodium acetate pH 5«0. The 
column was washed with the same buffer until the protein concentration 
fell below 0.02 mg/ml (Protein in mg/ml ^  1.55 x ^ 280 " O.76 x A )
The phosphotransferase activity was eluted with a gradient of 0.05 M
sodium acetate pH 5«0 to 0.05 M sodium acetate pH 4*0 (100 ml of each). 
The fractions were assayed as described below. The fractions 
containing the peak of activity were pooled and dialysed against water 
overnight.
The enzyme solution (60 ml) was found to contain 48 units/ml.
1 Unit transfers 1 j j l mole of phosphate per hour under the 
conditions described below.
The enzyme was stored frozen at -20°.
Assay for CPTase activity
Equal volumes of enzyme solution and assay mixture (containing 
40 mM cytidine and 200 mM sodium phenylphosphate adjusted to pH 5«0 
with acetic acid) were incubated at 37° for 1 hour.
100/Jil was assayed for inorganic phosphate as described in 
chapter 1.
10 /xl was spotted on to a cellulose thin layer plate and
developed in solvent system (l). The appearance of a spot with
R^ = 0.25 corresponding to cytidine 5'-monophosphate indicated
the presence of phosphotransferase activity.
Isoxanthosine 5'-monophosphate
Isoxanthosine (300 mg) was dissolved in a solution (25 ml)
containing phenylphosphate (0.4 M) and sodium acetate (0.1 M) at
pH 5«0. Carrot nucleoside phosphotransferase solution (2 ml, 96 units)
was added and the mixture incubated at 35°• The reaction was followed
by descending paper chromatography in solvent system (l). After 2
days, when the yield of the product approached its peak, the reaction
was neutralised with ammonium hydroxide and chromatographed on DEAE-
Sephadex. The unreacted nucleoside was collected for re-use.
Isoxanthosine 5'-monophosphate was obtained in a yield of 30$ as
determined by ultraviolet absorption.
The product was one spot on a PEI-cellulose plate developed in
solvent system (2). R^  = O.65.
The ultraviolet spectra at pH 5*0 showed A = 269 nmmax
( £ 10,500) and at pH 9.5 A = 287 nm (6 10,600).max
Isoxanthosine 5 '-diphosphate
The trie thy lammonium salt of isoxanthosine 5 '-monophosphate (120 mg) 
was dried by co-evaporation with pyridine under vacuum. The dry solid 
was dissolved in tributylamine (l80/*l) and HMPT (5 ml). Diphenyl- 
phosphorochloridate (180 jul) and tributylamine (216 jxl) were added 
and left for 30 mins. at room temperature. The solution was vigorously 
mixed with ether (50 ml) and petroleum ether (50 ml) and then left for 
30 mins. at 4°« The supernatant was decanted and the residue dissolved 
in pyridine (2 ml) and HMPT (2 ml). The pyridine was removed by
evaporation under vacuum.
An inorganic phosphate solution was prepared from phosphoric acid 
(l M, 720 JXl) and tributylamine (400 yUl). This mixture was dried
by co~evaporation with pyridine under vacuum. The residue was
dissolved in pyridine (2 ml) and mixed with the activated nucleotide
solution. The reaction was left for 30 mins. at room temperature and
then evaporated under vacuum. The residue was dissolved in water and
adjusted to pH 8.0 with ammonium hydroxide. The solution was
chromatographed on DEAE-Sephadex.
Isoxanthosine 5'“diphosphate was obtained in 2Qffn yield as
determined by ultraviolet absorption. The unreacted isoxanthosine
5'“monophosphate, which eluted from the column after the 5'“diphosphate,
was collected for re-use.
T.l.c. on a PEI-cellulose plate showed one spot when developed
in solvent system (2). R^. = 0.45*
The ultraviolet spectra at pH 5*0 showed X = 269 nm and
IliaX
at pH 9.5 X_fl„ = 287 nm.
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Polyis oxanthylate
The polymerisation mixture contained the following components in a 
total volume of 5*4 ml: sodium isoxanthosine 5'“diphosphate (350 un:i'^s)»
tris-HCl pH 8.2 (40 mM), MgC^ (2 mM), EDTA (2 mM) and polynucleotide 
phosphorylase from M. luteus (8 units/ml). The reaction was incubated 
at 35° for 24 hours. The yield of polymer, as determined by phosphate 
release, was 55
The protein was removed by phenol extraction. The aqueous layer
was chromatographed on G“75"Sephadex (40 x 1.8 cm) by elution with water.
The first fraction contained polyisoxanthylate and the remaining
isoxanthosine 5'“diphosphate was collected for re-use.
Polyisoxanthylate was one spot on a PEI-cellulose t.l.c plate
developed in solvent system (2). R^  = 0.0.
The ultraviolet spectra at pH 5*0 showed X = 272 nm and atmax
pH 9*5 A = 277 nm» The extinction coefficient at 272 nm and at max
pH 5.0 was 7500 as determined by phosphate analysis.
Gel electrophoresis gave an SgQ value of 12 S by comparison with 
known markers.
RESULTS AM) DISCUSSION
The synthesis of isoxanthosine was carried out by Dr. C. Domfeld 
by condensation of tris (trimethylsilyl) xanthine with tribenzoyl 
ribosyl bromide. Since the amount of nucleoside available for 
phosphorylation and subsequent polymerisation was quite small, it 
was important to use mild procedures which enabled the recovery of 
unreacted starting material.
Isoxanthosine was found to be a good substrate for carrot 
nucleoside phosphotransferase and isoxanthosine 5'"monophosphate 
was obtained in &  yield of J>Ofo after chromatography. It was 
possible to re-isolate the unreacted nucleoside as a mixture with the 
phosphate donor, phenylphosphate. This mixture was then re-cycled. 
Formation of the 3'"monophosphate was not detected during the 
phosphorylation.
Isoxanthosine 3'“diphosphate was conveniently prepared by the 
method of Michelson (1964). Although the yield of 2Qffo was very low 
for this step, diphenylphosphorochloridate is a very mild reagent and 
the majority of the remaining nucleotide was re-isolated in several 
fractions from a DEAE-Sephadex column. All these fractions showed 
ultraviolet spectra similar to isoxanthosine and probably consisted 
of various polyphosphates. Treatment with bacterial alkaline 
phosphatase gave a single product by t.l.c identical in R  ^to 
isoxanthosine.
The order of elution of the isoxanthosine phosphates from DEAE-
Sephadex was unusual. In particular, isoxanthosine 5'“diphosphate
was eluted at a lower ionic strength than isoxanthosine 5'“monophosphate
The most likely explanation for this lies in the close proximity of the
pH of the eluent (TEAB drifts from pH 7*5 to about pH 8.5 during the
course of chromatography) to the pK values of the nucleotides. Thesea
were measured by following the change in the ultraviolet absorption
with pH (Fig. 18). The pK values are: iso X, 7*95; iso XMP, 8.1;s»
iso XDP, 8.4» At pH values between 8.1 and 8 .4 both the mono- and
diphosphate would carry about 3 negative charges.
The enzymatic polymerisation of isoxanthosine 5'"diphosphate was
not successful under normal conditions (eg. tris-HCl pH 9*0, 150 mM ;
2+Mg ,10 mM; EDTA, 5 mM; nucleoside 5'“diphosphate, 20 to 30 mM). 
However, polymerisation of the related nucleotides, xanthosine 5'“ 
diphosphate and isoadenosine 5'“diphosphate, has been carried out under 
conditions of lower ionic strength, lower magnesium and lower pH
(Bachner and Massoulid, 1973; Michelson et al, 1966). Under similar
FIGURE 18
Change in ultraviolet absorption with pH for 
iX.iXMP.iXDP and poly(iX)
The test compound was dissolved in water and 
adjusted to a slightly acid pH by addition of HC1.
The ultraviolet absorption at 290 nm was recorded.
The pH of the solution was altered in small increments 
by addition of negligible volumes of concentrated 
sodium hydroxide. After each addition the pH and 
absorption at 290 nm were accurately recorded.
isoxanthosine (iX)
isoxanthosine 5'“monophosphate (iXMP) 
isoxanthosine 5'“diphosphate (iXDP) 
polyisoxanthylate

conditions (eg: tris-HCl pH 8.2, 40 mM? Mg^+, 2 iriM; EDTA, 2 mM)
53$ of isoxanthosine 5'“diphosphate was incorporated into polyisox- 
anthylate as determined by inorganic phosphate release.
Purification of polyisoxanthylate by phenol extraction and 
subsequent dialysis was not possible since the majority of the 
unreacted monomer did not diffuse out of the dialysis bag. The 
reason for this is not clear. However, it was possible to separate 
the polymer from the monomer by chromatography on G“75 Sephadex.
The difficulty experienced in separating polyisoxanthylate from 
the monomer may be related to the finding that under some conditions, 
particularly on heating, there is a considerable reduction in chain 
length of the polymer. In some cases degradation to the monomer was 
observed by t.l.c. Up to the present time, it has not been possible 
to specify the conditions which favour this degradation, although it 
was observed that as ionic strength increases the rate of degradation 
of polyisoxanthylate decreases. A similar phenomenon has been 
previously reported for the closely related polynucleotide, poly (X) 
and also for poly (A) (Fikus and Shugar, 1969 > Barszcz and Shugar, 1964)*
It was shown that polyisoxanthylate is indeed degraded by pancreatic
ribonuclease. It is very rare for a polypurine to be degraded by this
enzyme, another example being polyformycin (Ward and Reich, 1968). The
hyperchromic shift associated with complete degradation to component
nucleotides was 42$ at the A of 272 nm. This figure suggests amax
reasonably high amount of stacking between bases in the polynucleotide 
chain.
In the heating experiments discussed below, the reversibility of 
the hyperchromic shifts were checked and any cases in which they were 
poorly reversible, indicating excessive polymer breakdown, were rejected.
Further information regarding the structure of polyisoxanthylate 
was obtained by following the change in ultraviolet absorption with 
temperature (Fig. 19). The first part of the melting profile displays 
a non co-operative hyperchromic shift that would be expected from a 
stacked single-stranded polynucleotide. However, the sharp dis­
continuity at around 77° is very unusual. The drop in ultraviolet
FIGURE 19
Variation of ultraviolet absorption with temperature 
for polyisoxanthylate
Polyisoxanthylate was dissolved in 0.15 M NaCl and 
0.01 M cacodylate at pH 7*4-
Fresh poly(iX)
Poly(iX) after heating to 
90° and cooling
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absorption suggests a gain in secondary structure. This may arise 
from the formation of a self-complementary double-stranded helix.
Support for this suggestion comes from the observation that on cooling 
and reheating, the second melting profile is co-operative and more 
like that of a double helical structure. An alternative explanation 
could be that a conformational change has taken place leading to a 
more stable structure. Such a change may involve the syn-anti tautomeric 
forms of the base in relation to the sugar. If the bases adopted the 
usual anti conformation (ie with the imidazole ring lying next to the 
sugar), they would experience severe steric crowding around the 
imidazole ring; about as severe as the 2-keto group would experience 
if the alternative syn conformation were adopted. From model building 
studies it is apparent that there would be considerable hindrance to 
free rotation about the glycosidic bond.
It is possible, during the polynucleotide phosphorylase catalysed 
polymerisation of isoxanthosine 5'“diphosphate that nucleotides in a 
particular conformation are predominantly incorporated (Kapule.r et al, 
1970). Heating polyisoxanthylate may then induoe isomerisation within 
the component nucleotides to give the alternative conformation, 
presumably for thermodynamic reasons.
These ideas were tested by looking at the relative rates of 
enzymatic degradation of polyisoxanthylate before and after heating 
to 85°, since the rate may be highly dependent upon nucleotide 
conformation. The heated polymer was degraded by pancreatic 
ribonuclease 10 times faster than the non-heated polymer. This 
would favour an explanation of the syn - anti type rather than double­
helix formation, since pancreatic ribonuclease would not be expected 
to degrade a double-stranded complex faster than a single strand.- If 
the syn - anti hypothesis were true, the enzyme might be expected to 
degrade the polymer most quickly when it is in the form most like 
poly (U) ( ie with the 2-keto groups anti to the sugars).
In relation to the discontinuity in the melting profile of 
poly (iX) it is interesting to note the change in ultraviolet spectrum 
just before and just after the event.(Fig. 2.0). A distinct shoulder 
appears at about 315 nm after the event and then disappears on cooling.
FIGURE 20
Ultraviolet spectra of polyisoxanthylate at 
different temperatures
A solution of poly(iX) was made up in tris-HCl (100 mM), 
(5 nM), EDTA (0.5 mM) and phosphate pH 8.2 (200 mM). 
The ultraviolet spectrum was recorded at room temperature 
and then at 2° intervals between 70° and 90°• Only the 
relevant spectra are reproduced here.
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Determination of the p.K value for polyisoxanthylate gave thea
result shown in figure 17. The graph can be interpreted to give two
p.K values at 8 .4 and 10.5. However, the ionisation of polyisox- a
anthylate at pH 8 .4 is unlike the ionisation observed for the monomer,
since there is no associated shift in the X of the former.max
Probably as the pH is increased from 7*0» ionisation begins to occur 
and this induces the formation of a more stable secondary structure 
in which the ionisable hydrogen atom is involved in a hydrogen-bond.
This inhibits the removal of the proton up to a pH of 10.5* This 
effect is similar to that observed for poly (x) (Michelson and Monny,
1966); Bachner and Massouli£, 1973)•
The circular dichroism spectrum of polyisoxanthylate is shown 
in figure 21. It shows a positive peak with a maximum at 211 nm 
( 0 = 118,500) and a negative peak with a minimum at 259 nm ( 0 = -49,500).
Equimolar solutions of polyisoxanthylate and other homo­
polyribonucleotides in NaCl (0.15 M) and cacodylate pH 7*3 (0.01 M) were 
mixed in equal volumes. At room temperature no interaction was
detected with poly (G), poly (x), poly (l),poly (U), poly (c) and 
6poly (N -0HA). However, a hypochromic shift with a maximum at 
250 nm (llio) was detected on mixing poly (iX) and poly (a). Further 
study of this interaction is required to obtain information regarding 
the stoichiometry and properties of the complex. In view of the 
limited number of interactions observed between poly (iX) and other 
homopolynucleotides it would appear that poly (iX) does not resemble 
either poly (X) or poly (i) but that it is more like poly (u).
Nevertheless, the potential complex poly (iX). poly (A) may be 
interesting for interferon induction assays since it represents a 
rare purine-purine interaction.
No biological studies have yet been carried out on poly (iX).
FIGURE 21
Circular dichroism spectrum of polyisoxanthylate
Polyisoxanthylate was dissolved in 0.15 M NaCl and 
0.01 M cacodylate pH 7*4-
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CHAPTER 4
POLYTHIOFYRIMIDiNES
INTRODUCTION
Poly (c ) has been shown to possess antiviral activity in mice 
against EMCV by a mechanism thought to involve mimicry of the poly (c ) 
tract within the viral genome (stebbing et al, 1976a). Modification 
of poly (c )  by thiolation is particularly attractive owing to the 
versatility of a sulphur substituent. Thiolated derivatives of 
cytidine have been described previously in which a sulphur substituent 
has been introduced into the 2-, 4“ or 5“ position of the pyrimidine 
ring (compound numbers 24, 25, 26 and 27 in figure 22) (Scheit and 
Faerber, 1974; Ueda et al, 1968; Ueda et al, 1974; Ryu, 1976). Two 
other closely related nucleosides include the 2- and 5“thiouridines 
(compound numbers 28 and 29 in figure 22)(Szabo et_ al, 1970; Vorbruggen 
and Strehlke, 1973). All of the above derivatives have been enzymatically 
incorporated into homopolyribonucleotides (Bahr et al, 1973; Scheit and 
Faerber, 1971; Scheit and Gaertner, 1969a) except the 5“"thiopyrimidine 
5 '-diphosphates which are poor substrates for polynucleotide phosphorylase 
(Bardos ejb al, 1975)* The latter have been incorporated in a low ratio 
into copolymers by chemical thiolation of preformed polymers (Mikulski 
et al, 1973).
Thiolation of poly (c ) and poly (U) has been shown to have a 
varied effect on the properties of the polymer depending on the site 
of substitution. 4“Thio substitution is in general without significant 
effect whereas 2-thio groups stabilise a polynucleotide helix by virtue 
of vertical stacking interactions with neighbouring nucleotides. For 
example, poly (S^U) resembles poly (U) as far as its structural and 
biological properties and the stability of the complex with poly (A) are 
concerned (Scheit and Gaertner, 1969b). Poly (S c ) ,  on the other hand, 
forms a double-stranded complex with poly (i) more thermally stable
p
than poly (i). poly (c )  (Faerber e_t al, 1972). Similarly poly (S U)
and poly (S^ S^ Hj) do not complex with poly (A) but form very stable 
self-association complexes (Bahr et al, 1973).
Thiolation of pyrimidine bases in double-stranded polynucleotides 
is, in general, without significant effect on interferon induction 
(O'Malley et al, 1975; Reuss et al, 1976). Other biological
FIGURE 22
Chemical structure of thiolated •pyrimidine nucleosides
(24) 2-thiocytidine (S^ C)
(25) 4“thiouridine (S^ Hj)
(26) 2,4~3ithiouridine (S^ S^ Tl)
(27) 5~thiocytidine (S^ C)
(28) 2-thiouridine (S^ U)
(29) 5”thiouridine (S^ U)
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properties of single-stranded thiolated polynucleotides have not been 
widely investigated. However, it has been shown that polynucleotides 
containing 5”thiopyrimidine bases are good polymerase inhibitors in vitro 
(Chandra and Bardos, 1972; Srivastava, 1973) and that 2- or 4~thiolation 
has an inhibitory effect on protein synthesis in cell free systems 
(Lengyel and Chambers, I960; Bahr et al, 1973; Hochberg and Keren-Zur, 
1974).
This chapter describes improved methods for the synthesis of some 
of these polynucleotides and also contains some preliminary biological 
results. The activity against a viral reverse transcriptase is 
described in chapter 5»
EXPERIMENTAL
Materials
E. coli B cells were obtained from the Microbiological Research 
Establishment, Porton, Wiltshire, England.
Poly (C), poly (TJ) and uridine were obtained from P.L.
Biochemicals Inc.
2',3% 5'“tribenzoyluridine, l-*0-acetyl-2', 3'> 5'” 
tribenzoylribofuranose, 2-thiocytosine and 2-thiouridine were 
obtained from Sigma Chemical Company Ltd.
1, 2, 3, 4~tetrahydronaphthalene and stannous chloride were 
obtained from Hopkin and Williams.
Methods
Thin layer chromatography was carried out in the following 
solvent systems:
(1) 1 M Ammonium acetate/ethanol 1:1
(2) Toluene/acetic acid/water 5*5*1 
(5) Methanol/chloroform 10:90
(4) Methanol/chloroform 2:98
(5) n-Butanol/acetic acid/water 5*2:3*
E.coli Polynucleotide Phosphorylase
E.coli B cells (500 g) were mixed with buffer (it) containing 
tris/HCl pH 7*5 (20 mM), mercaptoethanol (l mM) and phenylmethane- 
sulphonylfluoride (2 mM) and warmed to 37°• Lysozyme (0.5 g) was 
added and stirred for 45 mins. Deoxyribonuclease (l mg) was added 
and stirred for 15 mins. The solution was centrifuged at 10,000 r.p.m. 
for 20 mins. and 4°* The supernatant was split into four fractions and 
each heated quickly to 55° (in a water bath at 75°) and kept at this 
temperature for 5 mins. They were cooled rapidly and spun at 
10,000 r.p.m. for 15 mins. at 4°* To the supernatant a 10$ solution 
of streptomycin sulphate pH 7*4 was added (50 ml per litre) dropwise. 
The solution was stirred for 15 mins. and centrifuged at 10,000 r.p.m. 
for 15 mins. at 4°* The supernatant was assayed as described below. 
Ammonium sulphate was added at 0° to 26$ saturation whilst keeping the 
solution at pH 7*5* The solution was stirred at 4° for 1 hour and 
spun for 30 mins. at 10,000 r.p.m. The supernatant was made up to
48$ saturation in ammonium sulphate and adjusted to pH 7«5* This was 
stirred at 4° for 1 hour and centrifuged at 10,000 r.p.m. for 30 mins.
The precipitate was dissolved in the minimum necessary volume of 20 mM 
tris-HCl pH 7*6 and dialysed overnight against the same buffer. The
solution was chromatographed on A50 DEAE-Sephadex (45 x 6.5 cm)
previously equilibrated with a solution of tris-HCl (20 mM) and
KC1 (0.25 M) pH 7.6 and 4°- The column was washed with the same 
buffer until all unbound protein was eluted. The polynucleotide 
phosphorylase was eluted with a gradient of 20 mM tris-HCl, 0.25 M 
KC1 pH 7.6 to 20 mM tris-HCl, 0.50 M KC1 pH 7.6 (2 * of each). Each 
tenth fraction of 12 ml was assayed as described below. The peak of 
enzyme activity was pooled and stored frozen at -20°.
The enzyme solution (600 ml) was found to contain 50 units/ml.
1 unit incorporates 1 ;umole nucleotide into polymer in one hour.
Assay for PNPase activity
Equal volumes of enzyme solution and assay mixture (containing 
20 mM Mg2+, 10 mM EDTA, 30 mM rADP and 0.3 M tris-HCl pH 9.0) were 
incubated at 37° for 30 mins. A sample was chromatographed on a 
cellulose thin layer plate in solvent system (l). The presence of 
polynucleotide phosphorylase was deduced from the presence of polymeric 
material with an of 0.0.
1 A
The activity of the enzyme was quantified using ( c)~rADP as a 
substrate and counting the amount of radioactivity incorporated into 
poly (A).
2-Thiocytidine
2-Thiocytosine (5g) was mixed, under dry conditions, with 
hexamethyldisilazane (79 ml), dioxane (47 ml) and trimethylchlorosilane 
(0.79 ml)- After refluxing for 4 days the dioxane and hexamethyl­
disilazane were removed by distillation. The product (5-2 g) was 
distilled at 130° under 0.5 mm mercury pressure. The oil (19-25 mmole) 
was dissolved in dry 1,2-dichloroethane (35 ml). 20 ml of this solution 
(containing 11 mmole) was mixed with l-0“acetyl-2',3*>5'“tribenzoyl- 
ribofuranose (10 mmole) in 1,2-dichloroethane (150 ml). Stannous 
chloride (li68 ml; 14-4 mmole) was added and left for 3 hours at room 
temperature. The reaction was followed by silica thin layer chromatography
in solvent system (2). The mixture was shaken with saturated 
potassium bicarbonate and filtered through hyflo. The organic 
layer was separated and dried with magnesium sulphate. The solution 
was evaporated to dryness and recrystallised from methanol to give 
5.2 g of 2',3',5'“tribenzoyl“2“thiocytidine. The solid was stirred 
overnight in saturated methanolic ammonia (100 ml). The reaction 
was followed by silica thin layer chromatography in solvent system (3)*
The solution was evaporated to dryness, dissolved in water (250 ml) 
and extracted twice with ether. The water layer was evaporated to 
dryness under vacuum. The product was recrystallised from water to 
give 1.6 g 2-thiocytidine.
The ultraviolet spectrum at pH 6.0 gave X = 250 nm and amax
shoulder at 272 nm and at pH 2.0 gave X  = 231 nm and 278 nm
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with a shoulder at 310 nm.
2,4-Dithiouridine
2 ',3 %5 '“Tribenzoyluridine (10 g) was dissolved in 1,2,3»4“ 
tetrahydronaphthalene (400 ml) at 70°. Phosphorus pentasulphide (20 g) 
and sodium sulphide (l g) were added and the mixture heated to 160° with 
vigorous stirring under a reflux condenser. The reaction was followed 
by silica thin layer chromatography in solvent system (4). After 1 
hour the 2 %3',5 ^ toibenzoyluridine with an R^  of 0.73 had disappeared 
giving a new spot with R^. 0.37* The 1,2,3»4”tetrahydronaphthalene 
was removed by vacuum distillation and the residue extracted with 
benzene. The benzene solution was chromatographed on silica (250 g).
The column (2.5 x 40 cm) was washed with benzene (500 ml) and the 
products eluted with 10$ ethylacetate in benzene (500 ml) followed by 
15$ ethylacetate in benzene (500 ml). Each tenth fraction of 10 ml 
was assayed by silica thin layer chromatography in solvent system (4)«
The fractions containing the product were evaporated to dryness and 
dissolved in sodium ethoxide solution (500 ml ethanol + 500 mg sodium). 
After 3 hours at 50° the solution was cooled and neutralised with hydrogen 
ion dowex. The resin was filtered -off and the solution evaporated to 
dryness under vacuum. The oil was dissolved in water and extracted
twice with chloroform. The water layer was evaporated to a solid
Tinder vacuum. 2,4"Dithiouridine was obtained in 35$ yield by weight.
The ultraviolet spectrum at pH 6.0 gave \  = 282 nm with amax
shoulder at 350 nm and at pH 9*0 gave \  = 280 nm and 320 nm.max
2,4"Dithiouridine 5'-monophosphate
A. Chemical Method
Dry 2,4”dithiouridine (100 mg) was dissolved in triethylphosphate 
(l ml) and water (l2yUl). The phosphorus oxychloride (0.4 nil) was 
added and the solution kept for 4 hours at 4°* Water (10 ml) was 
added slowly with vigorous stirring, keeping the temperature at 0° 
for 30 mins. The solution was neutralised with ammonium hydroxide 
and chromatographed on DEAE-Sephadex. 2 ,.4“Dithiouridine 5'“monophosphate 
was isolated in 80$ yield as determined by ultraviolet absorption.
B. Enzymatic Method
2,4~Dithiouridine (700 mg) was dissolved in water (120 ml) 
containing phenylphosphate (0 .4 M) and sodium acetate (O.IM) at 
pH 5.0. Carrot nucleoside phosphotransferase (100 units, 2 ml) was 
added and incubated at 35° for 4 days. The reaction was followed by 
descending paper chromatography in solvent system (5)* The spots 
were eluted with water and measured by ultraviolet absorption at 320 nm 
at pH 10.0. After neutralisation with ammonium hydroxide the product 
was chromatographed on DEAE-Sephadex. 2,4"Dithiouridine 5'-monophosphate 
was obtained in 40$ yield as determined by ultraviolet absorption.
2-Thiocytidine 5'"monophosphate was synthesised in 45$ yield by 
an identical method except that it was chromatographed on QAE-Sephadex 
in the formate ion form and eluted with a gradient of water to 1M 
formic acid.
2.4"Dithiouridine 5 '-diphosphate
2,4"Dithiouridine 5'"monophosphate (l mmole) was dried by 
co"evaporation with pyridine under vacuum. Tributylamine (2 mmole, 476yUl) 
and dioxane(10 ml) were added and shaken to dissolve the oil.
Diphenylphosphochloridate (2.5 mmole, 500yul) and tributylamine 
2.5 mmole, 600ji£L) were added and shaken for 30 mins. The solution 
was evaporated under vacuum to an oil and a mixture of ether (80 ml) 
and petroleum ether (80 ml) added. After thorough mixing the reaction
was left at 0° for 30 mins. The supernatant was decanted and the 
residue taken up in dioxaneand evaporated to dryness under vacuum.
The oil was dissolved in pyridine (4 ml).
An inorganic phosphate solution was prepared by mixing 1 M 
phosphoric acid (2 mmole, 2 ml) and tributylamine (4.6 mmole, 1.1 ml) 
and drying by co-evaporation with pyridine (4 ml) under vacuum. The 
two solutions were mixed and left for 30 mins. at room temperature.
This was evaporated to dryness, taken up in water, adjusted to 
pH 8.0 and chromatographed on DEAE-Sephadex. 2,4“Hithiouridine 
5'"diphosphate was obtained in 27$ yield as determined by ultraviolet 
absorption.
2-Thiocytidine 5'-diphosphate
2,4-Dithiouridine 5'“diphosphate (16 mg) was dissolved in water 
(4 ml) and 80 JLl 1 of a solution containing sodium sulphite (0.75 M) 
and sodium metabisulphite (0.25 M) added. Air was bubbled through the 
solution for 4 hours during which time a further 4 aliquots (80 jULl) 
of reagent were added. The reaction was followed by the loss of the 
320 nm chromophore. Ammonium chloride (86 mg) was added and adjusted 
with stirring to pH 8.5 by addition of ammonium hydroxide (l M). The 
solution was left for 16 hours at room temperature and chromatographed 
on DEAE-Sephadex. 2-Thiocytidine 5'"diphosphate was obtained in a 
yield of 50$ as determined by ultraviolet absorption.
Poly 2-thiocytidylate
2-Thiocytidine 5'"diphosphate (5 mg) was dissolved in a buffer (l m 
containing tris"HCl(0.13 M) and magnesium chloride (2.6 mM) at pH 8.3* 
Polynucleotide phosphorylase from E. coli (15 units, 0.3 ml) was added 
and incubated at 37° for 6 hours. The polymerisation was followed by 
release of inorganic phosphate. The solution was chromatographed on 
G"75 Sephadex (l cm x 10 cm) by elution with water. The first fraction 
containing the polymer, was purified as described previously. The 
second fraction containing 2-thiocytidine 5 '"diphosphate was stored for 
re-use. Poly (S C) was obtained in a yield of 30$ as determined by 
inorganic phosphate release.
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Poly 4-thiouridylate
Poly (C) (1.5 g) was dissolved in water (10 ml) to which pyridine 
(5 ml) was added. The solution was cooled to “70°• and liquid hydrogen 
sulphide (5 ml) added. The mixture was transferred to a 50 ml capacity 
bomb in which the pressure rose to 20 atm. The bomb was heated at 
37° for 12 days with occasional shaking. After release of the pressure, 
the solution was aspirated with air and dialysed against an aqueous 
solution of tris-HCl (50 mM), sodium chloride (50 mM) and EDTA (l mM) 
pH 9.0, followed by water alone. Poly (S^ U) was obtained in 
quantitative yield.
RESULTS AND DISCUSSION
The synthesis of polyribonucleotides containing 5”thio substituted 
pyrimidines has been described previously (Mikulski et al, 1973)*
However, it has not been possible to trace the full experimental details. 
The brief outline available involves treatment of either poly (c) or 
poly (U) with methylhypobromite in methanol followed by reaction with 
sodium sulphide in dimethylacetamide. It is claimed that this 
procedure converts up to 21$ of the pyrimidine bases to their 5”thio 
derivatives. It was found here, with poly (c), that the first stage 
of the conversion generally worked well and gave up to 100$ of the 
5,6-disubstituted adduct as observed by an almost total loss of 
ultraviolet absorption. However, treatment of this product with 
sodium sulphide generally caused reversion to poly (c), although, on 
occasions, a small amount of 5”bromocytidine was detected.' In the 
presence of dithiothreitol, to reduce possible disulphide linkages, 
no ultraviolet absorption at around 320 nm. corresponding to 5~fchiolation, 
was ever detected. It is interesting to note that an aqueous solution 
of a sulphide salt shows a maximum in the ultraviolet spectrum at 
about 320 nm.
Although the equivalent syntheses of 5”thio substituted pyrimidine 
nucleosides and nucleotides have been described in more detail (Szabo 
et al, 1970; Szekeres, 1971)» the latter are poor substrates for 
polynucleotide phosphorylase (Bardos et al, 1975) and ENA polymerase 
(Livingston et al, 1976). Other synthetic procedures for the 
preparation of 5~thiopyrimidine nucleosides are by the nature of the 
reaction, unsuitable for application to polynucleotides (Herr et al, 1956; 
Nagamachi et al, 1972). No further investigation has been carried out 
to overcome these problems.
Homopolynucleotides of S^ U, S^ S^ Hj, S^ C and S^ U have all been 
previously prepared by enzymatic polymerisation with polynucleotide 
phosphorylase (Simuth et al, 1970; Scheit and Faerber, 1971? Lengy^ l 
and Chambers, I96O; Faerber and Scheit, 1970). Synthesis of the last 
three polymers is made more difficult by the fact that the corresponding 
nucleosides are not commercially available.
Thiolation is classically carried out by reaction of a keto group 
with phosphorus pentasulphide in an inert solvent. By this method
1-methyl-2,4~clithiourac;Ll has been prepared from 1-methyluracil and 
similarly 2,4~dithiouridine from 2 0.3*,5'"*tribenzoyl-4“thiouridine 
(Brown and Harper, 1961; Ueda at al, 1968). It was found here that 
2,4“dithiouridine (26) could be more conveniently synthesised from the 
commercially available 2',3',5'“tribenzoyluridine (30) (Fig. 23) in a 
yield of 35$*
2,4~Dithiouridine has been converted directly to 2-thiocytidine by 
treatment with methanolic ammonia at a high temperature (Ueda et al, 1968) 
or by a milder method involving oxidation to the 4“sulphonate followed 
by substitution with ammonia (Scheit and Faerber, 1974)* For larger 
scale synthesis, 2-thiocytidine can be prepared by condensation of 
silylated 2-thiocytosine with the appropriately modified sugar moiety 
(Vorbruggen and Strehlke, 1973)• A modification of this general 
procedure has been published, employing a Friedel-Crafts catalyst 
(Niedballa and Vorbruggen, 1974)* This method, which generally gives 
purer products in high yield, was applied to the synthesis of 2- 
thiocytidine (24) and 2-thiouridine. The yields for the condensation 
steps were 95i° and 9Qffo respectively, an improvement over the original 
procedure.
The method of Yoshikawa et al, (1967) has been routinely used 
for the conversion of thiopyrimidines to their 5~nionophosphates. This 
method is favoured in most cases over the method of Strobach (1969) 
owing to the ease of operation and the high yields obtained. Yoshikawa 
claimed that the inclusion of a trace of water in the phosphorus 
oxychloride and triethylphosphate mixture encourages the specificity 
of the reaction for the 5’“Position of a nucleoside as well as increasing 
the yield. This addition was found to increase the yield of 2,4” 
dithiouridine 5 '-monophosphate from 50$ to 80$. In order to synthesise 
sufficient quantities of polythiopyrimidines for extensive biological 
studies, it was necessary to scale up the synthesis of the 5,f”raonophosphates 
to 1 g. This proved to be quite difficult in the cases of 4—thiouridine 
and 2,4“dithiouridine since yields were reduced and complications in 
the chromatography arose from the presence of side-products. The 
side-products in the 4“'thiouridine reaction were attributed to other 
phosphorylated species by analysis of ultraviolet absorption and 
t.l.c data. The products from 2,4“dithiouridine are discussed later.
FIGURE 25
Reaction scheme for the synthesis of S2S4U and S2C
(24) 2-thiocytidine
(26) 2,4"dithiouridine
(36) 2 % 3',5/"tribenzoyluridine
BsO
| INI I
| \ ] A )
(30)
0
BzO OBz
. HO" U o
2)G2H50Na
As
HO OH (26)
NH2
|nA s H
N H S i ( C H 3)3
N5^ SSi(CH3)3
*Vh2
N
n A s
BzO 1)KHCQ3. h°-UO
2)chpV nh3
BzO OB; HO OH (24)
These problems were overcome by the introduction of an enzymatic 
method for the preparation of the nucleoside 5'“monophosphates.
Nucleoside phosphotransferases from wheat shoots (Giziewicz and 
Shugar, 1975) and carrots (Brunngraber and Chargaff, 1967) have been 
used for the synthesis of modified nucleotides. The carrot nucleoside 
phosphotransferase is the more readily available, has a broad substrate 
specificity (Harvey at al, 1970) and can be prepared in large 
quantities (Marutzky et al, 1974)•
Attempts to immobilise carrot nucleoside phosphotransferase on 
cyanogen bromide activated Sepharose 4B and on titanium chloride 
activated cellulose were unsuccessful owing to a complete loss of 
activity. Since the enzyme was found to retain its activity over 
a period of several days at 37°> it was possible to optimise its use 
by keeping the enzyme concentration low. The enzymatic phosphorylations 
of S2C, s2s4u and S2U each gave yields of the 5’“monophosphate of 
about 45$. It was possible to recover the unreacted nucleoside, 
contaminated with phenylphosphate. This mixture was recycled.
Traces of the presumed 3’“monophosphates were detected in the reaction 
mixtures by t.l.c, but they were separated from the product by 
DEAE“Sephadex chromatography.
The literature procedure fo± the synthesis of thiopyrimidine - 
5’“diphosphates involves activation of the 5’“monophosphate with 1, 1’” 
carbonyldiimidazole (Cramer and Neunhoeffer, 1962) and subsequent 
displacement with inorganic phosphate. The value of this method was 
found to be limited by the frequent, complicated chromatographic 
profiles, particularly during the synthesis of 2,4“dithiouridine 
5’“diphosphate. Side reactions gave products related to those 
observed during the synthesis of the 5’"monophosphate.
The two major impurities were treated with bacterial alkaline 
phosphatase and purified by silica gel chromatography. The ultraviolet 
spectrum of one product showed a \ at 356 nm unaffected by either
IQ£L3C
acid or base, and the other product showed only end absorption. Both 
products could also be obtained by treatment of 2,4”.dithiouridine with 
1 , 1 carbonyldiimidazole in dimethylformamide. This type of reaction 
has been reported for uridine (Dra&ar et al,1976) and for the 
nucleosides (Maeda et al, 1977) in which the final products include
the 2,2’-(0)-anhydronucleosides (3l) and the 2', 3’"(o)-carbonyl 
derivatives (32)(Fig. 24). Similar compounds have been prepared with 
sulphur acting as the bridging atom (Ueda and Shibuya, 1974)* It is 
possible that the first side-product mentioned above is 2,2'-(s)- 
anhydro“4"thiouridine (33)• The second side-product is more difficult 
to account for, but the lack of ultraviolet absorption suggests a 
saturation of the 5»6-double bond. By analogy with 5’"thiouridine (34) 
(Bannister and Kagan, i960) which exists as 6,5’"(s)-anhydrouridine (35) 
it may be that the second side-product is 6,2’-(s)-anhydro“4"thiouridine (36) 
(Fig. 24). These assignments are based only on preliminary results at 
the present time. Further investigation may lead to the clarification 
of an interesting series of reactions.
An alternative method for the synthesis of 2,4"dithiouridine 
5’“diphosphate was employed by activation of the 5’“monophosphate with 
diphenylphosphorochloridate and subsequent displacement with inorganic 
phosphate (Michelson, 1964)* This phosphorylation procedure is milder 
than most others and consequently is more suitable for sensitive 
nucleotides. The diphenylphosphate group is very easily displaced 
by nucleophilic attack and thus nucleotides containing polyphosphates 
can be isolated if the reagent is not carefully removed after the 
activation step. Although the yields of the nucleoside 5’“diphosphates 
are generally low (27$ for 2,4"dithiouridine 5’"diphosphate), the 
unreacted 5’“monophosphate can be recovered and re“used.
It has been reported that the synthesis of 2,4"dithiouridine 
5 '“diphosphate from the corresponding nucleoside is easier than the 
equivalent synthesis of 2-thiocytidine 5’"diphosphate (Scheit and 
Faerber, 1974)* This was in fact found to be the case using the 
phosphorylation method of Michelson (1964), and consequently routine 
synthesis of 2-thiocytidine 5’"diphosphate was carried out by chemical 
conversion of 2,4"dithiouridine 5’"diphosphate.
Both 4"thiouridine 5’"diphosphate and 2,4"dithiouridine 5’" 
diphosphate are poor substrates for polynucleotide phosphorylase but 
can easily be incorporated into copolymers together with either uridine 
or cytidine 5 ’"diphosphate. The results of these polymerisations are 
presented in table 7» Figure 25 shows the kinetics of copolymerisation 
of 2,4"dithiouridine 5’"diphosphate with uridine 5’"diphosphate.
FIGURE 24
Proposed structure of some nucleoside derivatives
(31) 2,2’“(o)-anhydrouridine
(32) 2',3'“O“carbonyluridine
(33) 2,2 ’“(S)-anhydro“4"thiouridine
(34) 5’-thiouridine
(35) 6,5’“(S)"anhydrouridine
(36) 6,2’-(s)“anhydro“4"thiouridine
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TABLE 7
Co-polymerisation of S^ TJDP and S^ S^ HlPP with 
either UDP or CLP
The polymerisation reactions contained the following 
components:-
tris-HCl 0.1 M pH 8.2
Mg2+ 2 mM
total substrate 28 mM .
PNPase 11.5 units/ml.
The polymerisations containing S^ tTDP were carried out 
using PHPase from M.luteus and those containing 
S^ S^ HlDP with PNPase from E.coli.
The ratio of nucleotides in the polymer was 
calculated by applying the general formula below 
after complete degradation by pancreatic ribonuclease.
A,270
q4U
321 A525 *
S4TI
270
sV
525
c
270 270
c
325
The percentage polymerisation was calculated from 
the weight of lyophilised polymer.
TABLE 7
Ratio of nucleotides 
in substrate mixture
Ratio of 
nucleotides in 
polymer
io polymerisation
s'Hjdp s2s4ubp CDP UBP S^ UDP s2s4ubp CDP UDP
1 1 1 1.7 35
3 1 4 40
7 1 7.3 50
1 10 1 10.5 55
1 11 1 13 55
1 30 1 40 60
1 1 1 1.2 20
1 7 1 7 25
1 10 1 11 25
1 30 1 40 35
1 l - - 0
1 8 1 10 40
1 20 1 19 45
FIGURE 25
Kinetics of the co-polymerisation of S^ S^ UDP with UDP
The polymerisation reactions contained the following 
components:-
tris-HCl 0.1 M pH 8.2
Mg2+ 2 mM
total substrate 28 mM
PUPase 11.5 units/ml.
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In general there is only a slightly lower proportion of
thionucleotide found in the copolymers than was present in the
initial reaction mixture. However, the most significant effect
of the thiopyrimidine nucleotides on the polymerisation reaction
is to decrease the yield of the polymer. It has been shown
previously that the V  for the polymerisation of 4~thiouridinemax
5 '-diphosphate is 10 times smaller than for uridine 5'“diphosphate 
(Simuth ert al, 1970). Consequently, to prepare polymers containing 
a high percentage of thionucleotides it would be necessary to perform 
long incubations with a high concentration of enzyme. The limitations 
of this can be overcome by adopting the method of Hochberg and Keren-Zur 
(1974) whereby poly (c ) can be converted to poly (S^U) by treatment 
with liquid hydrogen sulphide. This method can be used on a 
relatively large scale to synthesise polymers,containing 4—fchiouridine 
residues. The conversion rate is shown in table 8. Under the 
conditions of the reaction the formation of small amounts of side- 
products cannot be completely ruled out even though on enzymatic 
digestion of the polymer only one spot was detected by t.l.c. Ellman's 
reagent (Ellman, 1959) which will detect thiol groups, gave a very 
weakly positive reaction. It is possible that a few thiophosphate 
intemucleotide linkages are produced. This possibility needs to 
be further investigated.
TABLE 8
Chemical preparation of polymers containing 4“~thiouridine
Poly(c) was dissolved in a water-pyridine mixture (2:1 v/v) 
and frozen to “70°• One volume of liquid hydrogen 
sulphide was added. The reaction was transferred to a 
bomb and left under the conditions outlined in the table.
The purification procedure has been described in 
the experimental section.
TABLE 8
Reaction
Time/Bays
Temp/°C io conversion
0 20 0
1 20 2
6 20 7
12 20 33
3 _ 37 25
6 37 67
10 37 90
12 37 92
17 37 100
BIOLOGICAL ACTIVITY
Polynucleotides containing thiopyrimidine bases were tested 
for biological activity in a variety of systems.
As analogues of poly (c) they were assayed for antiviral activity 
in mice against EMCV infection as described in Chapter 1. The 
survival data is presented in figures 15 and 16 in Chapter 2 and in 
figure 26.
Despite the variability in some of the results, none of the 
thiolated polynucleotides showed a significant enhancement of antiviral 
activity compared with poly (c). In fact the majority were 
significantly worse.
Through an association with Dr. D. McGeoch of Glasgow University 
thiolated polymers were tested by him as inhibitors of influenza 
virus transcriptase in vitro.
The procedure is based on the method of Bishop et al (1971) and 
is detailed in the legend to figure 27. Thiolation of poly (c).in 
the 2-position did not have much effect on the rate of transcription. 
However, as the ratio of 4“thiolated nucleotides in poly (c) increases, 
there is an increase in the inhibitory potency of the polymer. 
Increasing the 4“thiouridine content above 25$ has very little effect 
on the 50$ inhibition values, whilst the amount of polymer required 
for total inhibition is significantly reduced.
All the polynucleotides mentioned in this chapter were assayed 
against a viral reverse transcriptase as described in Chapter 6.
FIGURE 26
Protective effect of thiolated polynucleotides on 
EMCV infections in mice
Polynucleotides were dissolved in 0.89$ (w/v) 
sodium chloried and 10 mM HEPES buffer at pH 7*5 
to a concentration of 4 mg/ml. 100jjl 1 of this
solution was injected intravenously into BKW mice 
at six hours before infection with a 1 x 
dose of EMCV. Groups of about 20 mice were used 
for each treatment. The graph records the 
percentage survivors at a certain time in hours 
past infection. Records were made up twice daily.
Data supplied by N. Stebbing
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FIGURE 27
Anti~influenza virus properties of thiolated 
polynucleotides
The reaction mixture contained the following components:~
Polynucleotide 0.1 —» 300yiAg/ml
Tris-HCl pH 8.2 50 mM
KC1 150 mM
MgCl2 8 mM
MnCl2 0.2 mM
Dithiothreitol 5 mM
Nonidet P~40 0.596
ATP 2 mM
CTP 0.4 mM
(^ H)UTP (30ytACi^ tmc>1) 0,4 mM
GTP 0.2 mM
Fowl plague virus. Rostock strain 0.5->2
The mixture was incubated at 31 and 50 /aI samples removed 
and assayed for acid insoluble radioactivity.
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CHAPTER 5
STRATEGIC OLIGODEOXYNUCLEOTIDES 
INTRODUCTION
Significant progress in the understanding of oncornavirus 
replication has been achieved since the discovery of reverse 
transcriptase (Baltimore, 1970); Temin and Mitzutani, 1970)> as 
discussed in the general introduction. The initial deoxynucleotide 
sequence of the transcripts from two avian and one mammalian 
oncornavirus have recently been published (Taylor ejt al, 1974»
Eiden et al, 1975; Haseltine et al, 1976). They are d(AATGAAGC) 
for Rous Sarcoma Virus (RSV) and Avian Myeloblastosis Virus (AMV) 
and d(AATGAAAGA) for Moloney Murine Leukaemia Virus (MMLV). The 
remarkable conservation of the first six nucleotides by these 
viruses from different sub-groups suggests an important functional 
role for this sequence.
A synthetic hexadeoxynucleotide of this sequence is sufficiently 
long to form a complex with the complementary sequence in the tumour 
virus genome, adjacent to the tRNA primer. The presence of an 
oligonucleotide at this site during viral replication might be 
expected to have significant biological consequences. By blocking 
the 3'-end of the synthetic oligonucleotide it may be possible to 
inhibit elongation by preventing the formation of a normal diester 
linkage. Statistically, in a genome of 9000 nucleotides, there will 
be on average about 2 copies of any sequence six nucleotides long. 
Consequently, d(AATGAA) may bind to more than one site on the genome 
and hence increase the number of sites for initiation of transcription.
The oligonucleotides were' synthesised by colleagues within this 
department using enzymatic extension of oligomers made by the triester 
approach. They were tested for their effects on transcription of 
AMV RNA by AMV reverse transcriptase in vitro.
EXPERIMENTAL
Materials
All oligodeoxynucleotides were synthesised by Dr. G. Owen,
Dr. J. Josan, Dr. M. Eaton and Mr. T. Patel.
Plasma from chickens infected with AMV was a generous gift 
of W.J. Beard, Life Sciences Building, St. Petersberg, Florida.
AMV RNA-dependent DNA polymerase was purified by Dr. J.S. Emtage.
Snake venom phosphodiesterase was obtained from Worthington 
Biochemicals Ltd.
ribonuclease was obtained from Koch-Light Laboratories Ltd.
Pancreatic ribonuclease was obtained from the Sigma Chemical 
Company Ltd.■Z
( H)-dTTP was obtained from the Radiochemical Centre, Amersham.
dATP, dCTP, dGTP and dTTP were obtained from the Sigma Chemical 
Company Ltd.
NCS tissue solubiliser was obtained from Amersham/Searle.
Oligo d(A^ ) was obtained from P.L. Biochemicals Inc.
Isolation of AMV 70S RNA
Frozen chicken serum infected with AMV (100 ml) was thawed 
at room temperature and filtered under gravity through a double nybolt
filter into a 250 ml centrifuge pot. This was centrifuged at
3 o2.5 x 10 r.p.m. for 10 mins. at 2 in an MSE 4L centrifuge.
Kieselguhr (l g) was added to the supernatant and stirred for
5 mins. at 4°» After an identical sp^ n, the supernatant was
filtered through Whatman No. 1 paper on a Buchner funnel. The
filtrate was layered on to 6 ml glycerol contained in each of four
3
SW27 centrifuge tubes. These were spun at 25 x 10 r.p.m. for 
60 mins. at 2°. After removal of the supernatant, the virus 
interface was withdrawn and diluted to 60 ml. with a solution 
containing NaCl (150 mM), EDTA (l mM) and tris-HCl (10 mM) at 
pH 8.5. This was layered on to 6 ml of glycerol contained in 
each of two SW27 tubes and spun as before. The virus interface was 
removed and diluted to 36 ml with the same solution. This was 
layered over 12 ml of buffer containing 20$ glycerol which in turn
was layered over 6 ml glycerol in each of two SW27 tubes. This
3 owas centrifuged at 27 x 10 r.p.m. for 60 mins. at 2 . The virus
interface was removed in a small volume and made up to 10 ml with
a solution containing NaCl (150 mM), EDTA (l mM) and tris-HCl (10 mM)
at pH 8.5. The mixture was stored overnight at "70°. After thawing,'
sodium lauryl sulphate was added to a final concentration of 0.5$
and shaken for 5 mins. The solution was extracted twice with a
phenol/chloroform mixture and once with chloroform alone. Sodium
chloride was added to the aqueous phase to make it up to 0.2 M.
Two volumes of ethanol were added and the mixture left at “20° for
3
20 hours. This was centrifuged at 10 r.p.m. for 15 mins. The 
supernatant was decanted and the precipitate dissolved in 0.5 ml of 
a solution containing NaCl (0.1 M), EDTA (l mM) and tris-HCl (10 mM) 
at pH 7.4. This was layered on to a linear gradient of 10$—>30$ 
glycerol in the same buffer in an SW41 tube. This was centrifuged 
at 41 x 10^  r.p.m. for 3 hours at 4°» The gradient was passed through 
an ultraviolet absorption monitor and the fractions containing the 
70S RNA pooled. The solution was stored ready for use at “20°.
The solution contained O.67 &260 u212-^ 3/11!* Assuming an 
extinction coefficient of 10,000 this is equivalent to 67yumolar 
in polymer phosphate or 7*4 nmolar in polymer.
Assay Conditions
Each assay for the activity of the oligodeoxynucleotides 
against AMV RNA-dependent DNA polymerase contained the following 
components, unless otherwise specified in the text.
Total aqueous volume 50 jjlI
Tris-HCl pH 8.3 50 mM
Mg Cl2 6 mM
KC1 25 mM
Triton X-100 0.01$
dATP 200 jjM.
dCTP 200 yUM
dG-TP 200/aM
(5H)-dTTP 10/AM 60 yuCi/ml.
Dithiothreitol 5
AMV* 70S RNA 0.60 mM 5.4>uM phosphate
deoxyoligonucleotide lOyuM or 1 jmN or 0.1 yuM.
in polymer
Enzyme 4*5 Hnits/ml.
Each assay mixture was allowed to stand at room temperature 
before addition of the AMV RNA-dependent DNA polymerase. Incubations 
were performed at 25° for a fixed time interval. 40 /U of the 
solution was removed and spotted on to a 2.5 cm diameter GP/C (Whatman) 
filter disc. A solution containing 25 yug calf thymus DNA was spotted 
on to the same disc, which was then immersed into a solution of 10$ 
trichloroacetic acid and 5$ sodium pyrophosphate at 4°» After 10 mins. 
the disc was placed on a sinter funnel and washed thoroughly with
1) 10 ml 10$ trichloroacetic acid, 5$ sodium pyrophosphate
2) 10 ml 5$ " ” , 2-|$ " "
3) 10 ml 5$ " 1 in ethanol
4) 10 ml ethanol
5) 10 ml ether.
The disc was dried, placed into a scintillation vial and 
covered by 5 nil of toluene/2,5”diphenyloxazole (l,4“cli (2-(5“ 
phenyloxazolyl)) benzene) (POPOP) scintillant. The sample was 
counted on a Nuclear Chicago scintillation counter.
Each assay included a blank, for the determination of background 
radiation, and two controls, one in the absence of dligodeoxynucleotide 
and the other in the absence of both this and the enzyme. All
graphical points were corrected for background radiation.
Determination of the products of transcription
The synthetic oligonucleotide was labelled in the 5'-position 
20
with ( P)-phosphate by carrying out a reaction with the following 
components in a total volume of 500 julIi-
tris-HCl pH 7.6 66 mM
Mg2+ 10 mM
2-mercaptoethanol 16.7 mM
oligonucleotide 20 yUM
£-(52P)-rATP 100yuM (total 70/ACi)
polynucleotide kinase 3 units
(l unit transfers 1 nmole phosphate in 30 mins. at 37°•
The incubation was carried out for 5 hours at 37°• The solution 
was chromatographed on 3MM paper in 1M ammonium acetate/ethanol 1:1.
The baseline material was eluted with ammonia solution (0.01 M) and 
lyophilised.
The labelled oligonucleotide was added to the assay described above. 
Stimulation of transcription was demonstrated by counting for tritium 
as described. T^  ribonuclease (2^g) and pancreatic ribonuclease (2jug) 
were added to the remainder of the solution and incubated for 1 hour at 
37° • The protein was extracted twice with a phenol-chloroform mixture 
and once with chloroform. After addition of a dye marker (bromophenol 
blue and xylene cyanol FF) the sample was electrophoresed on a 20$ 
polyacrylamide slab gel overnight at 4°- The gel was cut into 1 cm 
long slices, placed separately in scintillation vials and incubated 
with NCS (3 ml) at 37° overnight. The samples were counted for 
tritium and in a toluene based scintillant.
Results and Discussion
The AMV RNA-dependent DNA polymerase used in this chapter was 
purified by the method of Kacian et al, 1971)» as far as CM“Sephadex 
C“50 chromatography. It was routinely stored in 50$ glycerol at 
“20°. Under the standard assay conditions described by Kacian et al 
the enzyme solution was found to contain 450 units/ml. One unit is 
defined as the amount of enzyme which polymerises 1 nmole of nucleotide 
in 10 mins. at 37° using poly (A)/oligo(dT) as template/primer.
The oligonucleotides used in this chapter were synthesised by a 
combination of ‘triester* and enzymatic methods (josan et al, 1977)* 
d(AAT) was prepared by stepwise chemical synthesis and then used as a 
primer for polynucleotide phosphorylase catalysed addition of 
deoxynucleoside 5'“diphosphates. Using this procedure it was possible 
to isolate and purify products of different chain lengths. All the 
deoxyoligonucleotides were analysed by the "wandering spot" procedure 
(Sanger et al, 1965) an<^ were shown to be more than 95$ pure.
AMV was chosen for this study since it is the most readily 
available of the tumour viruses and the purification of both the 
viral RNA and the reverse transcriptase have been described (Kacian et. al, 
197l)« Consequently, it was possible to set up a reconstituted in vitro 
assay system dependent on only a few parameters. In order to maximise 
the possibility of forming a double-stranded complex between the 
synthetic oligonucleotide and the complementary sequence within the 
viral genome, the incubations were carried out at 25°.
RNA-dependent DNA polymerase can be regarded as having several 
substrates in this assay, the nucleoside triphosphates and the 
AMV 70S RNA.< For the purpose' of the kinetic experiments described 
here the deoxynucleoside 5'“triphosphates were used in a large excess 
so that rates were dependent only on the concentration of the AMV RNA.
The effect of reducing the temperature on the rate of transcription
can be seen in figure 28. The K and V values for the reaction D m max
at 25 were calculated graphically as shown in figure 29. They were 
found to be 0,69yUmolar and 1.7 pmole/ml/min respectively. The AMV 
70S RNA was used at a concentration of 5«4yW.molar in the assays.
FIGURE 28
Variation in the rate of transcription with temperature
The reaction mixture contained the components described 
in the methods section. The total volume was 
200jjl and ^0jjil samples were removed at the times 
indicated.
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FIGURE 29
Variation of initial velocity with substrate concentration
The reaction mixture contained the components described in 
the methods section. The enzyme concentration was 
changed to 3*6 units/ml. The initial velocity was 
measured over the first 10 mins. of reaction.
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The effect of the various oligodeoxynucleotides on the rate of
incorporation of radioactivity into acid insoluble material can be
seen in table 9« The oligonucleotides can be divided into three 
distinct classes dependent upon their effect in the assay.
The smaller molecules, ranging in size from a dimer to a
pentamer, all showed some slight inhibition of transcription. This 
probably arises from a non-specific type of inhibition of the enzyme.
The second class includes d(AATGA£), d(AATGA^ ) and d(AATGA^ ) all 
of which stimulated transcription. The stimulation, which is 
concentration dependent, increases in the order dCAATGA^ ) < d(AATGA^ ) < 
d(AATGA^). It is unlikely that the effect is caused by direct 
activation of reverse transcriptase since it has been shown that the 
enzyme does not bind to the related sequence d(AATGAAGC)(Haseltine 
and Baltimore, 1976).
This octanucleotide represents the initial sequence of the DNA 
transcribed from the AMV RNA genome adjacent to the tRNA primer.
Hence the complementary sequence in the genome is (3 '”5 O r(^ A-CUTJCG). 
Although it cannot be ruled out that this is not a unique sequence it 
is likely that the synthetic oligonucleotide d(AATGA2) is binding to 
this region and is acting as a primer. The observed stimulation may 
arise from either the presence of a longer base paired structure or 
from the related finding that a DNA primer is more efficient than a 
RNA primer for the transcription reaction (Spiegelman et al, 1970).
Having shown that d(AATGA^ ) is a good stimulator it might have 
been expected that an extension of this sequence with non-complementary 
nucleotides would produce a good inhibitor. However, this was not the 
case and d(AATGA^ ) and d(AATGA^ ) were better stimulators than d(AATGA2). 
Assuming that the synthetic oligonucleotides are all acting by the 
same mechanism, adjacent to the tRNA primer, then non hydrogen-bonded 
adenosine residues may be expected to reduce the rate of initiation of 
transcription since the 3*“hydroxyl group is no longer in close proximity 
to the template. Consequently, it is interesting to consider the initial 
sequence of transcription in the presence of the synthetic oligomer 
d(AATGA^). It is unlikely that the terminal adenosine residues are 
removed before transcription by an associated enzyme activity, since 
this would require an extra reaction step. The adenosine residues 
may floop out’ giving rise to an extended sequence of d(AATGAAAAGC )
TABLE 9
Effect of various synthetic oligodeoxynucleotides 
on AMV RNA-dependent DNA polymerase
The assay procedure is described in the methods 
section.
All the figures represent the counts incorporated 
into acid insoluble material over a period of 25 mins, 
after allowing for background radiation, and are all 
related to the control experiment, with no added 
oligomer.
Most of the results represent an average value 
taken from different experiments.
d(AATGAn) represents a mixture of oligomers 
where n lies between 7 and 10.
TABLE 9
Oligomer
Relative Rate
0.1 molar 1.0 molar 10 molar
None 1 1 1
d(AA) 0.51 0.38 0.32
d(AAT) 0.36 0.36 0.33
d(AATG) 0.30 0.29 0.38
d(AATGA) 0.37 0.58 0.57
d(AATGA2) 1.18 4*68 8.86
d(AATGA^ ) 1.59 6.86 11.25
d(AATGA4) 1.16 8.50 12.96
d(AATGA^ ) 0.57 0.79 0.94
d(AATGA6) 0.70 0.60 0.80
d(AATGAn) 0.70 0.50 0.50
p(dA)6 2.60 0.50 0.60
or alternatively transcription may continue normally leaving unpaired
bases and giving rise to d(AATGAAAA ). It would be of interest
to determine the sequence since it would lead to a clearer understanding 
of the mechanism involved.
It has recently been shown that the terminal adenosine residue 
of the tRNA^ r  ^primer in RSV is not hydrogen-bonded to the viral 
genome (Cordell et al, 1976). It is however incorporated into the 
product of transcription leaving behind a mis-matched base pair.
If the non hydrogen-bonded adenosine residues in the oligomers behave 
analogously then the second alternative given above would be the 
correct one. Why this enzyme should favour a non hydrogen-bonded 
terminus on its primer is not clear.
The third class of compounds includes the synthetic oligonucleotides 
with the formula d(AATGA^ ) where n = 5 or more. All were found to be 
slight inhibitors of transcription. It would seem that, if these 
oligomers are binding to the same region of the genome, the non 
hydrogen-bonded tail is too long to allow efficient priming.
An oligonucleotide which would help clarify the mechanism of 
stimulation is the completely complementary compound d(AATGAAGC).
This would resolve the question as to the importance of the 1loose' 
nucleotides.
In vitro it is difficult to prepare a complete double-stranded 
DNA copy of the tumour virus genomes. The 5 '"terminus of the genome 
usually presents a 'strong stop' point and transcription products 
110 nucleotides long accumulate. However, under favourable conditions 
it is possible to exceed this length (Haseltine at al, 1976) presumably
by some mechanism involving circularisation to the 3'"end of the
template, as suggested by Haseltine et al, 1977 and Schwartz et al,
1977* The size distribution of the products from the experiments 
described here was the same with or without synthetic oligonucleotide 
and were appreciably larger than 110 nucleotides.
The value of the in vitro reconstituted assay system is limited
by the fact that it does not entirely mimic the in vivo situation.
For example, many cellular components are absent and these may have 
an important influence on the effects shown by the synthetic 
oligonucleotides. It may be possible to demonstrate a similar
activity in a more real situation, perhaps using virus particles 
rendered partially permeable by treatment with non-ionic detergents 
(Fujinaga et al, 1970) or in cell culture (Tennant et al, 1973)*
For the future it is important to demonstrate that the synthetic 
oligonucleotides are incorporated into the transcription products.
A preliminary experiment with this in mind has already been carried 
out but it proved to be negative. Assuming that incorporation does 
occur it will then be possible to design compounds capable of inhibiting 
transcription. For example, the 3'“terminus of a good stimulator 
could be blocked to prevent elongation. This could involve either 
removal of the 3'“hydroxyl group or modification with a bulky group 
such as tetrahydropyran.
However, d(AATGA^ ) is a good stimulator and if it were 
incorporated into the product it would result in a mutation in the 
virus which could in itself be deleterious.
CHAPTER 6
INHIBITION OF REVERSE TRANSCRIPTASE BY POLYRIBONUCLEOTIDES 
INTRODUCTION
The previous chapter investigated the possibility of inhibiting 
tumour virus replication by interfering with a strategic nucleic acid 
sequence within the viral genome. An alternative approach to selective 
inhibition is to find a compound capable of binding directly to the 
RNA-dependent DNA polymerase. Since the enzyme is virus coded then 
such a selective compound may not be toxic to the host polymerases.
It is not clear whether the mode of action of tumour virus reverse 
transcriptase is processive or distributive in nature (Leis, 1976;
Dube and Loeb, 1976). However it has been shown that the enzyme can 
dissociate itself from an actively synthesising complex and reassociate 
with an unprimed template. The latter, lacking a suitable primer 
3'"hydroxyl group is not sufficient for transcription (Gillespie et al, 
1975)- Many single-stranded polyribonucleotides compete for the 
template binding site on reverse transcriptase without acting as templates 
for the polymerisation reaction (Spiegelman et al, 1970)• Consequently 
many polynucleotides have been tested as inhibitors of this and similar 
enzymes in an actively synthesising system (Tuominen and Kenney, 1971?
Arya et, al, 1975; Erickson and Grosch, 1974; Srivastava, 1975; DeClercq 
et al, 1975; Green et al, 1974)* Although polynucleotides have not 
shown an absolute specificity in their inhibition of either viral or 
cellular polymerases, they have shown some selectivity.
Minor changes in the chemical composition of polynucleotides has 
had a significant effect on their interaction with polymerase enzymes.
For example, thiolation (Srivastava, 1973) in the 5"Position of 
pyrimidine bases or modification of the 2'-hydroxyl group of the sugar 
has increased their inhibitory activity.
These studies have been successfully extended to infected cell 
cultures (Tennant et al, 1973; DeClercq at al, 1975; Arya et al, 1976b; 
Arya, 1977) where the inhibitory action is believed to involve reverse 
transcriptase. The most recent results suggest that the inhibitory 
effect resides in a single-stranded molecule and that in general purine 
polynucleotides are more potent (Arya and Chawda, 1977; Arya et al.
1976a).
Suppression of tumour virus infection has been demonstrated 
in vivo (Tennant et al, 1974)• The necessary selectivity may be
aided by the high pinocytotic activity characteristic of many tumour 
cells (Liebeskind et al, 1971; Trouet et al, 1972).
Some polyribonucleotides have been shown to inhibit cellular 
polymerases, although in general the viral enzymes are more susceptible 
(Srivastava et al, 1973; Arya et al, 1976b; Abrell et al, 1972).
The presence of poly (A), poly (i), poly (uj and poly (c) does not 
affect the population growth rate of normal cells (Arya et al, 1976a).
All the polynucleotides described elsewhere in this thesis were 
assayed in the same reconstituted AMV system described in Chapter 5* 
This approach may assist in the understanding of the complex structure- 
function relationships.
EXPERIMENTAL
Poly (i) of different chain lengths was prepared by sonication
of a solution of material with an Sor. of 23S. Five minutes was20,w
sufficient to reduce the Sork to 9S.20,w
Assay Procedure
Each assay for the activity of the polyribonucleotides against 
RNA-dependent DNA polymerase contained the following components in 
a total volime of 40/(l.
Tris-HCl pH 8.3 50 mM
MgCl2 6 mM
KC1 25 mM
Triton X“100 0.01#
dATP 200 /aM
dCTP 200/aM
dGTP 200jjlVL
( H)"dTTP 10jjlM 60 fxGl/ml.
Dithiothreitol 5 mM
AMV 70S RNA 0.60 riM 5*4/xM phosphate
Polyribonucleotide 500 nM IOO^ aM phosphate
or 50 nM 10^M "
or 5 nM lyuM »
or 0.5 nM 0.1 /aM “
Enzyme 4.5 units/ml.
The polymer phosphate concentrations were calculated from 
predetermined extinction coefficients and converted to polymer 
molarity on the assumption that the average chain length was 
200 nucleotides.
Each assay mixture was allowed to stand at 25° for 30 mins. 
before addition of the enzyme. Incubations were performed at 37° 
for 40 mins. 35/*1 of the solution was removed and counted for 
radioactivity as described previously.
RESULTS AND DISCUSSION
The assay system used to study the effect of polyribonucleotides 
on reverse transcriptase was siMlar to that described in the previous 
chapter except that incubations were carried out at 37° •
The percentage inhibition of transcription exhibited by various 
concentrations of the polyribonucleotides is shown in figures 30, 31 >
32 and 33• The polymer concentrations required to inhibit transcription 
by 50fo are shown in table 10. The corresponding nucleosides showed 
no inhibition at similar concentrations.
The most important result to come from these figures is the effect 
of thiolation. Poly (S^ U) and poly(S^ C) gave 50$ inhibition at 
0.17/Amolar which in terms of the number of molecules is only a 3‘.2 
excess over the AMV RNA template (Pig. 30). In relation to their 
parent polynucleotides, poly (U) and poly (c), they are more potent 
inhibitors by at least two orders of magnitude. In addition, a 
gradual increase in potency is observed as the degree of thiolation 
increases (Pig. 3l). This was also evident with the copolymers of 
inosine and 6-thioinosine (Pig. 32).
The effect of varying the chain length was determined for poly (i). 
The concentration of polymer phosphate was kept constant and thus 
the effective polymer molarity increased as the, size was reduced.
There was no significant effect due to size on the inhibition of 
reverse transcriptase (Pig. 33). The change in size from an SgQ ■ 
of 23S to an S^q of 9S corresponds approximately to a difference 
in chain length from 2000 to 500 nucleotides. Thus, over this range 
there was a four-fold change in the effective polymer molarity. It 
has been observed that the inhibitory potency of poly (U) drops sharply 
with chain lengths below 200 nucleotides (Erickson et al, 1973). It 
would be of interest to determine whether poly (i) shows the same 
effect. However, from the result for varying chain lengths of poly (i), 
it is likely that any slight differences between the sizes of the 
various polynucleotides used in this chapter would not have a serious 
effect on their relative inhibition values.
It has been suggested that polypurine nucleotides are generally 
more effective as inhibitors of viral reverse transcriptase than 
polypyrimidine nucleotides (Arya e_t al, 1976a). The results 
presented in this chapter do not appear to follow the same rule.
FIGURES 50, 51, 52 and 55
Inhibition of reverse transcriptase by various 
polyribonucleotides
The assay conditions are described in the
experimental section.
All the polynucleotides were selected to
have an S0<- value of about 10 to 12S. This 20,w
corresponds to chain lengths of between 
500 to 1000 nucleotides.
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TABLE 10
Polynucleotide concentration required to give 50$ 
inhibition of transcription
The values are taken from figures 30>31> 32 
and 33*
The polynucleotides have been arbitrarily- 
divided into three classes depending on their 
relative potency.
*** s 50$ inhibition by < lyumolar
** m 50$ inhibition by < 10/4molar
* s 50$ inhibition by < 100 ^umolar
TABLE 10
** *
polydyS^U) 0.10 poly(x) 1.5 poly(l54,S6l) 11
poly(S^ B) 0.15 poly(l10,S6l) 2.0 poly(l) 14
poly(S2C) 0.17 poly(U10,S^ U) 2.3 poly(TJ) 15
poly(l,S6I2) 0.20 poly(l40,S6l) 8.7 poly(l74,S6l) 15
poly(U18,S2S4U) 0.30 poly(C13,S4U) 10 . poly(l84,S6l) 58
polyCU^S^4!!) 0.35 poly(N^ -OHA) 50
poly(0H5c) 0.67
poly(l2,S6!) 0.81
The kinetics of inhibition for polynucleotides in similar 
systems have been reported previously (Arya et al, 1976b; Mikke 
et al, 1976; arya at al, 1975). Plots of the reciprocal of 
initial velocity versus the reciprocal of inhibitor concentration 
show marked deviations from linearity at high concentrations.
The data suggests a partially competitive type of inhibition.
It seems that chemical modification of polynucleotides might 
result in improvement of their antiviral activity. The introduction 
of sulphur appears to be a lead worth pursuing.
CONCLUSION
It has been possible to synthesise a number of potentially 
antiviral polynucleotides containing unnatural bases by a combination 
of chemical and enzymatic procedures. In general enzymatic methods 
are preferred, where possible, since no problems associated with 
chemical modification occur.
It has proved difficult to design potential interferon inducing 
polynucleotides with heterocyclic base modifications due to the 
subsequent lack of double-stranded hydrogen-bond formation. However, 
the most interesting biological results to arise from this thesis 
come from the experiments involving an in vitro reconstituted tumour 
virus assay system. The finding that specific sequence oligonucleotides, 
complementary to a strategic region within the viral genome, can 
stimulate transcription, suggests that suitable modification will 
result in specific inhibitors for these viruses. Alternatively 
thiolation of certain polyribonucleotides has resulted in compounds 
with a high inhibitory potency against the tumour virus reverse 
transcriptase and also against an influenza replicase.
For the future it is important to understand more thoroughly 
these mechanisms of inhibition and to ascertain possible clinical 
value from tissue culture and in vivo assays.
APPENDIX
EFFECT OF BLOOD SERUM ON POLYRIBONUCLEOTIDES 
INTRODUCTION
For a potentially antiviral polynucleotide to be of clinical 
value it must prevent viral replication in the tissues of a living 
animal. In relation to its in vitro activity this demands that 
a number of extra considerations must be taken into account. For 
example, the solubility in body fuilds, the mode of administration, 
the presence of modifying enzymes, the ability to reach the affected 
tissue and its selectivity.
It has been shown that intravenous injection can be successfully 
used for the administration of polynucleotides (Stebbing et al, 1976a)» 
However, in order to understand the mechanism of in vivo activity it 
is important to identify the active species. Mammalian tissues and 
body fluids contain a variety of ribonucleases.(Roth, 1963; Barnard, 1969). 
In particular, animal sera oontains a ribonuclease specific for double­
stranded RNA (Stern, 1970) and also other less specific ribonucleases 
(Schmuckler et al, 1975; VonTigerstrom and Manchak, 1976). Recently
a human serum ribonuclease has been isolated (Reddi, 1975). This
appendix describes the effect of mouse and human serum on some 
polyribonucleotides and discusses how the results modify antiviral 
strategy.
EXPERIMENTAL
Serum from mice and humans was obtained by allowing whole blood 
to clot at room temperature for 7 hours. The supernatant was 
collected and stored at -20°.
Effect of serum on -polynucleotides 
Optical Method
The polynucleotide was dissolved in HEPES buffered saline 
solution to give a final concentration of about 1 
The solution was placed in a cuvette with a 1 cm path length and 
equilibrated at 37° in a Pye-Unicam SP1800 ultraviolet spectro­
photometer. Blood serum was added to a final dilution of sixty-fold. 
The variation of ultraviolet absorption at 2J0 nm with time was recorded 
Chromatographic Method
A concentrated solution of a radiolabelled polynucleotide was
1 2+ made up in a solution containing tris-HCl (20 mM) and Mg (10 mM)
at pH 7*4* A certain volume, containing approximately 50>ug, was
added to blood serum to give a final volume of 100 JU1. The mixture
was incubated at 37° and samples removed after various time intervals.
Each sample was spotted on to the baseline of Whatman 3MM paper, sprayed
with acetone and dried in a stream of warm air. The paper was
chromatographed in 1M ammonium acetate/ethanol 1:1. The baseline
spots were cut out and counted for radioactivity.
RESULTS AND DISCUSSION
Enzymatic degradation of a polynucleotide results in an increase 
in its ultraviolet absorption. This fact provides a method for 
studying the degradative effect of blood serum on polynucleotides.
However, it suffers from the disadvantage that blood serum itself 
has a high absorbance in the relevant region of the ultraviolet 
spectrum and thus it was necessary to dilute the serum at least 
sixty-fold. The increase in absorbance for each polymer was compared 
with the total hyperchromicity values determined by complete digestion 
with snake venom phosphodiesterase, pancreatic ribonuclease and 
bacterial alkaline phosphatase. These were found to be for 
poly(c) 40$ for tRNA 45$» and for rRNA 55$•
Poly(c) was very resistant to degradation by mouse serum at a 
sixty-fold dilution with a hyperchromic shift of only 2fo of the 
maximum occuring in one hour. In contrast, tRNA and rRNA reached 
equilibrium after 30 mins. at which point 35$ of the total hyperchromic 
shift had been attained. After addition of and incubation with 
SVPDase, pancreatic ribonuclease and BAP the hyperchromic shifts 
reached 45$ of the maximum for poly(c), 55$ for tRNA and 55$ for rRNA. 
Although it cannot be excluded that the total hyperchromicity for these 
polymers is different in serum, it would appear that a certain fraction 
of each is resistant to degradation. It must be remembered that the 
figures do not relate to the percentage of phosphodiester bonds 
broken since even a small oligomer can have a high hyperchromicity.
To overcome the limitations of this procedure a chromatographic 
method was developed using radiolabelled polynucleotides. The method 
elutes from the baseline all oligomers less than about six nucleotides 
long. The percentage of each polymer remaining on the baseline after 
a certain time can be seen in table 11.
Human blood serum contains considerably more ribonuclease activity 
than mouse blood serum and is generally non-specific towards the 
substrate. However, it appears to leave a resistant ^ore* in the 
case of the polypurine nucleotides poly(A) and poly(G). In contrast 
mouse serum degrades heteropolynucleotides faster than homopolynucleotides. 
Since poly(A) and poly(G) were not degraded at all, this may indicate
TABLE 11
Degradation of polynucleotides by blood serum
The conditions are described in the experimental 
section.
The figures represent the percentage of material 
remaining on the baseline after chromatography. This 
material will contain oligomers longer than six 
nucleotides.
— > indicates that 8.5 JtXS SVPDase, 2 jug pancreatic 
ribonuclease and 5/Ag of BAP were added.
TABLE 11
Mouse Blood Serum
Time/
mins
poly(c) poly(A) poly(G) EMCV
RNA
rRNA poly (A) poly(c) poly(G) EMCV
RNA
0 100 100 100 100 100 100 100 100 100
5 - - - 43 - 26 6 40 41
10 - - - 40 - - - - -
15 97 100 98 34 93 - - - 14
30 98 97 100 29 92 - - - 13
60 90 99 98 19 81 26 6 40 —
\ \ \
70 - 46 - 62 - 69 — 65 — - - 12
90 - 15 54 69 - 66 - - - - -
120 69 5 100 35 100 73 61 - - - 9
150 - 12 - - -
240 - 8 - - - 6
Human Blood Serum
that they are not substrates for the serum enzymes or alternatively 
there may be some factor in the serum protecting the polynucleotides 
from degradation. The latter seems most likely since the addition 
of vast amounts of ribonucleases still did not completely degrade 
the polymers.
It has been suggested that the use of polynucleotides in vivo 
stimulates the production of ribonucleases. Consequently, a similar 
set of experiments to those described above was carried out with 
blood serum taken from mice which had been treated 6 hours previously 
with either poly(A), poly(C) or poly(G). No difference between these 
sera or the controls was detected.
Autoradiography of the chromatography papers showed material 
corresponding to monomeric products. There was very little trace 
of small oligomers, suggesting that the enzymes responsible for the 
degradation are mainly exonucleases.
It has been shown that poly(c) is removed very rapidly from the 
bloodstream of mice (stebbing et al, 1977)* Assuming that a similar 
effect occurs with other polynucleotides in mice, then the rates of 
degradation observed in this appendix will not be sufficient to 
have a significant effect on the length of the polymers. However, 
this is not the case with human serum. The very rapid .rate of 
degradation of the homopolynucleotides will have to be taken into 
account for human antiviral polynucleotide strategy.
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